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C haracterisation  of high-affinity , ch loride-dependent L -glutam ate tran sp o rt in 
glial tu m o u r cells.
The rap id  and  efficient rem oval of the n e u ro tra n sm itte r  L-glutam ate from  
the synaptic cleft is m ed iated  by a specific group  of excitatory am ino  acid 
tran sp o rte r (EAAT) p ro teins. These p ro teins are p o stu la ted  to con tribu te  to 
signal te rm in a tio n , the recycling of tran sm itte r and  the  m ain tenance of L- 
g lu tam ate  below  excitotoxic concentrations. Of these pro teins the so d iu m - 
dependen t, h igh-affin ity  systems have been the  m ost th o ro u g h ly  
characterised in the m am m alian  central nervous system . The presence of a 
second L -glutam ate tran sp o rt system d istingu ished  by it's  dependence o n  
chloride and  n o t so d iu m  has been dem onstra ted . In the  present study , the  
high-affin ity , L -glutam ate transport system s p resen t in a series o f glial 
tu m o u r cell lines (i.e. LRM55, U-373, U-87, SNB-19, CCF-STTG1 and SW-1088) 
w ere investigated . It w as dem onstrated  using  ionic substitu tion  that L- 
g lu tam ate  tran sp o rt w as m ediated by both  so d iu m -d ep en d en t and ch lo ride- 
d ep en d en t up take. The expression of ch lo ride-dependen t uptake appeared  to 
be up regu la ted  in the glial tum ours, accounting  for 35 - 86% of total L- 
g lu tam ate  tran sp o rt in glial tum our cells. C onversely, the  so d iu m -d ep en d en t 
tran spo rt activ ity  w as a ttenuated . Pharm acological analysis of the ch lo ride- 
d ep en d en t tran sp o rt revealed  a profile d istinct from  the  so d iu m -d ep en d en t 
system . K now n inh ib ito rs of sod ium -dependen t tran sp o rt (e.g., D-aspartate, 
d ihydrokainate , L-frans-2,4-pyrrolidine dicarboxylate, 2,4-
m ethanopyrro lid ine-2 ,4-d icarboxylate  and L-anti-endo-2>,A-
m ethanopy rro lid ine  dicarboxylate) exhibited little or no  activity as inh ib ito rs. 
Several EAA analogues defined the pharm acological profile  of the ch lo ride- 
d ep en d en t system , notably  L-glutam ate up take  w as potently  and  
com petitive ly  inh ib ited  by L-cystine, L-quisqualate, (RS)-4- 
b rom ohom oibo tena te , ibotenate, L-hom ocysteate and  L-serine-O -sulphate. 
This profile w as found to exhibit sim ilarity to the pharm acological profile of a 
cy stin e /g lu tam a te  exchanger term ed system  xc. In the  final portion  of the  
study, w e cloned system  xc' to exam ine ch lo rid e-d ep en d en t transport of L- 
g lu tam ate  via this exchanger. cDNA sequences cod ing  the two p ro te in s 
com prising  system  xc\  xCT and  4F2hc, w ere isolated from  a m ouse brain  
cDNA library. Co-injection of xCT and 4F2hc into Xenopus oocytes resu lted  in  
the expression of ch lo ride-dependent L-glutam ate up take . Further, the library 
of p rev iously  iden tified  ch lo ride-dependen t tran spo rt inh ib ito rs p roduced  a 
sim ilar in h ib itio n  of L-glutam ate up take in system  xc\  These find ings 
dem onstra te  the use  of glial tum our cells as a m odel system  to study ch lo ride- 
d ep en d en t L -glu tam ate transport. They su p p o rt the existence of a d istinc t 
ph arm aco p h o re  for ch lo ride-dependen t g lu tam ate  b in d in g  and suggest an  
identity  w ith  system  xc\
Research advisor: R ichard J. Bridges, Ph.D.
u
R e p ro d u c e d  with perm iss ion  of th e  copyright ow ner.  F u r th e r  reproduction  prohibited without perm iss ion .
TABLE OF CONTENTS
A bstract.......................................................................................................................................ii
List of Tables.............................................................................................................................iv
List of Figures............................................................................................................................v
A cknow ledgem ents............................................................................................................. vii
C hapter 1: B ackground and  In troduction ....................................................................... 1
C hapter 2: M ethods and  M aterials..................................................................................13
C hapter 3: Pharm acology of H igh-Affinity, L-Glutamate
T ransport in LRM55 Glioma C ells............................................................ 21
C hapter 4: Pharm acology of High-Affinity, C hloride-D ependent
L -G lutam ate in Glial T um our Cell Lines................................................51
C hapter 5: C loning an d  Expression of the  C ystine/G lu tam ate
Exchange Transporter, system  xc'...............................................................64
C hapter 6: Sum m ary  and  Conclusions......................................................................... 85
Bibliography............................................................................................................................ 92
iii
R e p ro d u c e d  with perm iss ion  of th e  copyright ow ner.  F u r th e r  reproduction  prohibited without perm iss ion .
LIST OF TABLES
Table 3.1. Ionic dependence of [3H]-L-glutamate up take
in LRM55 gliom a cells.................................................................................... 35
Table 3.2. Inactive EAA analogues at the ch lo ride-dependen t
[3H ]-L-glutam ate uptake site in LRM55 gliom a cells........................... 40
Table 3.3. Potent inhibitors of high-affinity, ch lo ride-dependen t
[3H ]-L-glutam ate uptake in LRM55 gliom a cells.................................. 44
Table 3.4. 1^ values for inhibitors of high-affinity, ch lo ride-dependen t
[3H ]-L-glutam ate uptake in LRM55 gliom a cells...................................50
Table 4.1. Ionic dependence of [3H]-L-glutamate up take
in hum an  glial tum our cell lines................................................................ 61
Table 4.2. Inhib itory  activities of EAA analogues on  ch loride-dependent
[3H ]-L-glutam ate uptake in hum an glial tu m o u r cell lines..............62
i v
R e p ro d u c e d  with perm iss ion  of th e  copyright ow ner.  F u r th e r  reproduction  prohibited without perm iss ion .
LIST OF FIGURES
Figure 1.1. Excitatory am ino acid synapse ..................................................................... 10
Figure 3.1. Kinetic characterisation  of [3H ]-L-glutam ate up take  into
LRM55 gliom a cells in  the presence of sod ium  and  chloride  36
Figure 3.2. Kinetic characterisation  of [3H ]-L-glutam ate up take  into
LRM55 gliom a cells in the  presence of sod ium ....................................37
F igure 3.3. Kinetic characterisation  of [3H ]-L-glutam ate up take  into
LRM55 gliom a cells in the presence of ch loride...................................38
Figure 3.4. W estern b lo t analysis of high-affinity, sod ium -dependen t
L-glutam ate tran spo rte rs  in the LRM55 gliom a cell line.................. 39
Figure 3.5. C om petitive inhib ition  of ch lo ride-dependent [3H ]-L -glu tam ate
uptake into LRM55 gliom a cells by L-cystine......................................... 47
F igure 3.6. C om petitive inhib ition  of ch lo ride-dependent [3H ]-L -glu tam ate
uptake into LRM55 gliom a cells by L -quisqualate............................... 48
Figure 3.7. C om petitive inhib ition  of ch loride-dependent [3H ]-L -glu tam ate
uptake into LRM55 gliom a cells by (RS)-4-BrHI...................................49
Figure 5.1. Total RNA and  poly  (A )'-enriched  m RNA
isolated from LRM55 gliom a cells..............................................................73
Figure 5.2. Tim e-course for expression  of ch lo ride-dependen t transport in
Xenopus oocytes injected w ith  LRM55 gliom a cell m R N A  74
v
R e p ro d u c e d  with p e rm iss ion  of th e  copyrigh t ow ner.  F u r th e r  rep roduction  prohibited w ithout perm iss ion .
Figure 5.3. Pharm acological com parison ch lo ride-dependen t tran spo rt in
Xenopus oocytes expressing  LRM55 gliom a cell m R N A .................. 75
Figure 5.4. Isolation of xCT cD N A  sequences from
from  m ouse cD N A  libraries.........................................................................76
Figure 5.5. Isolation of 4F2hc cDNA sequences from
from m ouse cD N A  libraries.........................................................................77
Figure 5.6. Restriction d igest of the pOGl-xCT p lasm id .......................................... 78
Figure 5.7. Restriction d igest of the pBSK-4F2hc p lasm id .......................................79
Figure 5.8. A lignm ent of p red ic ted  amino acid sequences for xCT
isolated from  m ouse  m acrophages and  b ra in ....................................... 80
Figure 5.9. A lignm ent of p red ic ted  am ino acid sequences for 4F2hc
isolated from  m ouse  m acrophages and  b ra in ....................................... 81
Figure 5.10. Isolation of xCT and  4F2hc mRNA transcribed  in vitro
from  linearised p lasm ids pOGl-xCT and  pBSK-4F2hc....................82
Figure 5.11. Tim e-course for the  expression of ch lo ride-dependen t 
L -g lu tam ate  u p tak e  in Xenopus oocytes injected w ith
mRNA of 4F2hc a n d /o r  xCT..................................................................... 83
Figure 5.12. Pharm acological characterisation of ch lo ride-dependen t 
L -glutam ate u p tak e  in Xenopus oocytes injected w ith  
4F2hc and  xCT m R N A .................................................................................84
v i
R e p ro d u c e d  with p e rm iss ion  of th e  copyrigh t ow ner.  F u r th e r  rep roduction  prohibited w ithout perm iss ion .
ACKNOWLEDGMENTS
The com pletion  of this research project w as the resu lt of the efforts of a 
special group of indiv iduals. This study  is the cu lm ination  of their tim e and 
devotion  as m uch  as it is m ine and  therefore w ith  sincere gratitude I 
acknow ledge th a t help. The first and  greatest acknow ledgem ent belongs to 
m y research adv iso r and m entor, Dr. R ichard Bridges, for his guidance, 
su p p o rt and friendsh ip  th ro u g h o u t m y tim e in M ontana. It has been an  
h o n o u r to w ork  w ith  you. I express m y gratitude to Dr. N ick C handler, 
Dr. Diana Lurie, Dr. Keith Parker, and  Dr. Charles T h o m p so n  for the ir 
insightful advice and  discussions. Special thanks to those w ho helped on the 
project in M issoula; A ngela Dake, Benjam in M ickleson, Brady W arren , 
Sherry Colem an, and  Dr. M ichael M innick and  at the V ollum  Institute in 
Portland; Shirin A rastru , A nastassios Tzingounis, Jacques W adiche, and Dr. 
M ichael K avanaugh. Thanks to Dr. V ernon G rund and the D epartm ent of 
Pharm aceutical Sciences for g iving m e the opportun ity  to w ork, study and 
play in Big Sky C ountry . I w ould  like m ake a special acknow ledgem ent to my 
fellow graduate  s tu d en ts  and  colleagues, both past and  presen t, for your 
support and friendsh ip , especially Richard Bartlett, H ans Koch, V eronica 
Karpiak, D anielle D auenhauer, W. W allace W ebster, Tom  O rtiz and Jeff 
Sorbel. A special m en tion  for A m anda, M att, Vicki and  R on T huesen, my 
surrogate A m erican fam ily. A nd finally I acknow ledge m y m other, father
v ii
R e p ro d u c e d  with perm iss ion  of th e  copyright ow ner.  F u r th e r  reproduction  prohibited without perm iss ion .
and brother; Indira, A m rat and  Viresh. All this is possible because of your 
love and su p p o rt th roughou t m y life, all m y accom plishm ents are  yours for 
you have instilled the sp irit in m e to succeed.
v iii
R e p ro d u c e d  with perm iss ion  of th e  copyright ow ner.  F u r th e r  reproduction  prohibited without perm iss ion .
A  man is but the product o f his thoughts, 
what he thinks he becomes.
M ohandas K. G andhi
I X
R e p ro d u c e d  with perm iss ion  of th e  copyright ow ner.  F u r the r  reproduction  prohibited without perm iss ion .
Chapter 1: Background and Introduction
L-G lutam ate is now  w idely  considered as the p rim ary  excitatory 
n eu ro tra n sm itte r  in the m am m alian  central nervous system  (CNS). T his 
acidic a-am ino  acid m ediates standard  fast synaptic  in te rn e u ro n a l 
transm ission , as w ell as the com plex signal processing in v o lv ed  in learn ing , 
m em ory and  developm ental p lasticity  (for review  see: C o tm an e t al., 1995). L- 
G lu tam ate  perform s these d iverse  functions th rough  the activa tion  of both  
ionotrop ic  (ion channel-coupled) and  m etabotropic (second m essenger- 
coupled) excitatory am ino acid (EAA) receptors subclasses (Figure 1.1). T he 
ionotropic receptors w ere in itially  identified a n d  d is tingu ished  
pharm acologically  by the selective agonists for which they  w ere nam ed, i.e., 
N -m ethyl-D -aspartate  (NM DA), a-am ino-3-hydroxy-5-m ethyl-4-isoxazole 
prop ionate  (AMPA) and  kainate (KA). These receptors typically gate cu rren ts  
carried  by Na", K* and  Ca2" ions (for rev iew  see: D ingledine et al., 1999). T he 
m etabotropic g lu tam ate  receptors (mGluRs) were orig inally  characterised and  
nam ed  after the agonists trans-l-am inocyclopentane-l,3 -d icarboxylate  (trans- 
ACPD) and L -2-am ino-phosphonobu ty ra te  (L-AP4), an d  are coupled via 
guan ine  nucleotide  b ind ing  p ro teins (G proteins) to 3', 5'-cyclic adenosine  
m onophosphate  (cAMP) and  phosphoinosito l (PI) second m essenger system s, 
respectively (Conn and  Pin, 1997).
C ontradictory  to its role in  excitatory tran sm ission , excessive 
stim ulation  of EAA receptors by elevated  levels of L -glutam ate can result in a
1
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type of neuronal dam age know n as excitotoxicity (R othm an and Olney, 1987; 
Choi, 1988; Choi, 1994; R othm an and  O lney, 1995). This pathology can be 
d iv ided  into tw o distinct phases. The acute phase, w hich is m arked by cell 
sw elling, occurs as a result of an ino rd ina te  influx of Na~ through activated 
EAA receptors, followed by passive influx of Cl' and  water. The chronic phase 
is triggered by the d isrup tion  of Ca2* hom eostasis by influx th rough  N M D A  
receptors, as w ell as from release of in trace llu lar Ca2'  stores. Elevated Ca2* 
concentrations resu lt in the activation of proteolytic and  lipolytic enzym es, an 
increase in  free radical p roduction , apoptosis and  eventual cellu lar 
degenera tion  (for review see: Choi, 1995). Excitotoxic neuropathology is 
th o u g h t to be a factor in a num ber of CNS pathologies, including acute 
in juries such as stroke, ischem ia, anoxia and  traum a, as well as chronic 
neu ro d eg en era tiv e  syndrom es, such as am yotrophic lateral sclerosis (ALS), 
H u n tin g to n s 's  disease and A lzheim er's disease (Choi, 1994; Rothm an and 
Olney, 1995; Leigh and M eldrum , 1996; A rzberger et al., 1997; Olney et al.,
1997)
The ability of L-glutam ate to participate  in  so m any facets of n e u ro n a l 
com m unication  and  neuropathology necessitates that its concentration in the 
extracellular environm ent be carefully regulated . It is in this capacity that the 
im portance of the high-affinity L -glutam ate tran spo rt systems have come to 
be recognised. The rapid and  efficient clearance of extracellular L-glutam ate 
into neu rones and  astrocytes by these up take  system s has been postulated to 
contribute  to recycling the transm itter, te rm ina ting  the excitatory signal and
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pro tecting  n eu rones from  L -glu tam ate-m ediated  in ju ry  (for review  see: 
T akahash i et al., 1997). The p rim ary  excitatory am ino  acid transporters 
(EAATs) to w hich  these functions are  ascribed are the h igh-affin ity , sod ium - 
d ep en d en t L-glutam ate transporte rs  (for review  see: G egelashvili and  
Schousboe, 1999; V andenberg, 1998). Several subtypes of so d iu m -d ep e n d en t 
L -glutam ate transporters have been iso lated  and cloned from  m a m m a lia n  
tissue, includ ing  GLAST and  GLT-1 from  ra t brain, and  EAAC-1 from  rabbit 
intestine (Kanai and  Hediger, 1992; P ines et al., 1992; Storck et al., 1992). T he 
h u m an  hom ologues of these tran sp o rte rs  have also been  iden tified  and are 
referred to as EAAT1, EAAT2, and  EAAT3 (Arriza et al., 1994). Studies of 
cellu lar expression indicate that EAAT1/GLAST and EAAT2/GLT-1 are 
p resen t p rim arily  on astrocytes, w hereas the EAAT3/EAAC-1 subtype is 
preferentially  found on  neu rones (for review  see: G egelashvili and
Schousboe, 1998). More recent investiga tions have revealed  tw o add itional 
h u m an  subtypes, EAAT4 and  EAAT5 w hich  have been respectively  isolated 
from  cerebellar tissue and retina (Fairm an et al., 1995; A rriza  et al., 1997).
The identification of po ten t an d  selective inh ib ito rs has allow ed these 
up take system s to be characterised pharm acologically  (C ham berla in  et al.,
1998). The acyclic structure of L -glutam ate allows it to assum e a w ide range of 
conform ations due to the un restric ted  ro ta tion  and fo ld ing  of the m olecule. 
R estriction of this free m o v em en t th ro u g h  the in tro d u c tio n  of ring system s 
greatly reduces the num ber of L -glu tam ate con fo rm ations that these 
analogues can mimic. As a consequence, the num ber of b ind ing  sites these
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com pounds can  occupy is decreased , thereby increasing selectivity. The use of 
confo rm ationally  constrained  analogues of L -glutam ate has led to the  
d ev e lopm en t of a variety of u p tak e  inhibitors that have been  used  to define 
so d iu m -d ep en d en t tran sp o rte r b ind ing  site pharm acophores, i.e. L-frrms-2,4- 
py rro lid ine  dicarboxylate (L-frans-2,4-PDC), L-anti-endo-3,4:- 
m eth an o p y rro lid in e  dicarboxylate (L-anfz-erctfo-3,4-MPDC), (2S,3S,4R)-2- 
(carboxycyclopropyl)glycine (L-CCG-HI) and  2 ,4 -m ethanopyrro lid ine  
dicarboxylate (2,4-MPDC) an d  (for review  see: Bridges et al., 1999).
A second uptake system  th a t is capable of tran spo rting  L-glutam ate has 
been iden tified  based u p o n  its independence  of sod ium  and  dependence o n  
chloride. The origin of this site  w as first delineated  by b ind ing  studies, ra ther 
than  uptake assays, ow ing to the low level of expression of th is system  in  
classic biochem ical p rep ara tio n s such as synaptosom es and  prim ary  glial 
cultures (Bridges et al., 1986; Bridges et al., 1987a; Bridges et al., 1987b). Initial 
investigations into the n a tu re  of this site suggested its iden tity  w ith  the L- 
AP4-like receptor, as one of the  first identified  inh ib ito rs of chloride- 
dependen t [3H]-L-glutam ate b ind ing  w as L-AP4 (Fagg et al., 1983). Subsequent 
stud ies dem onstrated , how ever, that this ch lo ride-dependen t site could be 
pharm acologically  resolved from  the L-AP4 recep tor-m ediated  responses 
(Bridges et al., 1986). A m ajo r step in the characterisation  of the chloride- 
dep en d en t site  was the d e m o n s tra tio n  of its d ifferential d istribu tion  in the 
CNS. Q uan tita tive  rad io ligand  au to rad iog raphy  utilised [3H]-D-aspartate to
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selectively label sod ium -dependen t transporters and  [3H]-L-glutamate, in  
sod ium  free buffers, to label the ch lo ride-dependen t system  (A nderson  et al., 
1990; A nderson  et al., 1991). C onsistent w ith  the greater activity an d  
prevalence of the sod ium -dependen t system s, the Bmax of the ch lo ride- 
dependen t [3H ]-L-glutam ate site in rat brain  w as 5-fold low er than  its so d iu m  
counterpart. There w ere how ever, regions in the  rat brain  w hich exhibited  
relatively low  levels of sod ium -dependen t b ind ing , b u t relatively high leve ls 
of ch loride-dependent b ind ing  e.g., ou ter layers of the parietal cortex, d en ta te  
gyrus, s tria tum  and  thalam us. This led to the suggestion that th e  
contribution of each transporte r to total L -glutam ate up take capacity m ay vary  
am ong anatom ical regions. Further, it w as dem onstra ted  that de-lip idation  of 
the brain tissue sections w ith xylene could e lim inate  the sequestration  of 
substrate that occurred over the du ra tion  of the  b ind ing  studies. In a d d itio n  
to this sequestration, the  b ind ing  was also found  to be osm otically sen s itiv e  
and  to participate in the process of heteroexchange, properties m uch m o re  
consistent w ith  transport than  receptor b ind ing  (Pin et al., 1984; Fagg an d  
L anthom , 1985; Zaczek e t al., 1987).
The ability to differentiate the sod ium  an d  chloride system s a llow ed  
the pharm acological specificity of each to be m ore readily deduced. W ell 
know n blockers of sod iu m -d ep en d en t uptake (P-ffrreo-OH-aspartate and L- 
cysteic acid) effectively inhib ited  [3H]-D-aspartate uptake, bu t had  little effect 
on  ch loride-dependen t [3H]-L-glutam ate binding . Conversely, L-a- 
am inoadipate, L -quisqualate and ibotenate preferentially  blocked the chloride-
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d ep en d en t b inding, w ith little effect o n  sod ium -dependen t up take  (Bridges 
et al., 1986; A nderson et al., 1990);. A no ther significant advance in  th e  
characterisa tion  of ch loride-dependent tran sp o rt system s stem m ed  from  the  
observation  that L-cystine acted as a p o ten t inhibitor (Kessler et al., 1987). 
W hile L-cystine displayed inh ib ito r activity in the au to rad io g rap h ic  
characterisation, it appeared less effective than  w ould be predicted. This m ay 
be as a resu lt of the reduction of L-cystine to L-cysteine, w hich  is a re la tive ly  
poor inhib itor.
T ransport studies in a n u m b er o f  culture cell lines (e.g., C-6 g liom a 
cells, UC11 astrocytoma cells, LRM55 gliom a cells and  N18-RE-105 
re tinob lastom a cells) proved in s tru m e n ta l in delineating the ch lo ride- 
d ep en d en t L-glutam ate uptake system  because the cells exhibited h igh  leve ls 
of activity. Significantly, L-glutam ate u p tak e  in LRM55 cells w as inh ib ited  by 
L-cystine, an  finding that p ro v id ed  a pharm acological link to the  
cy stin e /g lu tam ate  exchanger, system  xc" (W aniew ski and  M artin , 1984; 
M urphy  et al., 1989; Cho and Bannai, 1990; Johnson and Johnson, 1993). T he 
m ajority  of the inform ation on system  xc' comes from the studies of its 
activity in fibroblasts (Bannai and  K itam ura, 1980; Bannai and  K itam u ra , 
1981; Bannai and Ishii, 1982; Bannai an d  K itam ura, 1982), a lthough  reports  
also indicate it's presence in a n u m b e r of different prim ary  cell c u ltu re  
system s, including: hepatocytes (T akada and  Bannai, 1984), a lveo lar type II 
cells (Knickelbein et al., 1997), m acrophages (W atanabe and  Bannai, 1987), 
renal tubu le  cells (Foreman et al., 1986) and um bilical vein endo thelia l cells
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(E w adh et al., 1988). Both L-glutam ate and L-cystine serve as substra tes an d  
com petitive  inh ib ito rs  of tran sp o rt and , in each case, up take  is ch lo ride- 
d e p e n d e n t an d  sod ium -independen t.
The recen t cloning of system  xc' from  activa ted  m ouse m acrophages has 
p ro v id ed  sign ifican t insight in to  the m olecu lar basis of the tran sp o rte r an d  
allow ed a m eans to investigate its activity in iso lated  expression system s (Sato 
e t al., 1999). System  xc' is a h e te ro m u ltim eric  po lypeptide  com prised of tw o 
d istinct p ro te in s, 4F2 heavy chain  (4F2hc) an d  xCT. The 4F2hc pro tein , a lso 
know n  as CD98, represents the heavy chain o f a cell surface an tigen  w hich  is 
d istribu ted  ub iqu itously  in m am m alian  cells. It is hypo thesised  tha t th is  
p ro te in  serves as a m odula to r of a fam ily of tran spo rte rs  th a t m ediate  a m in o  
acid exchange (N akam ura, 1999). Thus, 4F2hc has been found to induce a 
n u m b er of d ifferen t am ino acid transport system s (e.g., L, y*L and  b0*) w h e n  
co-expressed in Xenopus  oocytes or o ther he te ro logous expression system s 
(for rev iew  see Palacin et al., 1998).
xCT w as identified  as a novel p ro te in  com prised  of 502 am ino acids 
w ith  12 p u ta tiv e  transm em brane  dom ains (Sato et al., 1999). This p ro te in  is 
believed  to accoun t for the exchange p roperties  of system  xc\  It w as found to 
bear considerab le  hom ology to proteins that m ed ia te  the tran sp o rt of cationic 
and zw itterion ic  am ino acids w hen co-expressed w ith  4F2hc. The role of 
system  xc' u n d e r physiological conditions ap p ea rs  to function as an  obligate 
exchanger, m ed ia tin g  the exchange of ex tracellu lar L-cystine for in trace llu la r  
L -glutam ate. The direction of exchange is m ark ed ly  influenced by the h ig h
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in trace llu lar concentration  of L-glutam ate and  the  relatively  low in trace llu lar 
con cen tra tio n  of L-cystine (i.e., it is rap id  reduced  to L-cysteine). Similar to 
the ch lo rid e-d ep en d en t up take, system  xc' is po ten tly  inh ib ited  by L- 
qu isqualate , L -hom ocysteate and  L -a-am inoad ipate  (Bannai and  Ishii, 1982). 
B iochem ically, the accum ulation  of in tracellu lar L-cysteine th rough  system  x.' 
appears to p lay a p ivo ta l role as a ra te -lim itin g  step in g lu ta th io n e  
b iosyn thesis (Bannai, 1984b). G lu ta th ione  is th e  m ajor in trace llu la r thiol in  
m am m alia n  cells and  a key in term ediate  in  a w ide range of biochem ical 
processes such  as, detoxification, m etabolism  a n d  excretion of drugs. It is also 
serves as a p ro tec tan t against oxidative dam age  (M eister and  A nderson, 1983; 
M eister, 1991; M eister, 1995).
T he w ork  deta iled  in the present s tu d y  w as conducted  in three phases. 
First, the activ ity  of so d iu m -d ep en d en t and  ch lo rid e-d ep en d en t, h igh-affin ity  
L -glu tam ate tran sp o rt system s in the LRM55 gliom a cells w as quantified to 
establish  the levels of activity  of each system , as w ell as their respective 
pharm aco log ica l profiles. T ow ard this goal, severa l series of EAA analogues 
w ere tested  for the ability to inhibit the h igh-affin ity , ch lo ride-dependen t 
tran sp o rt o f [3H ]-L-glutam ate in  LRM55 cells. This pharm acological and  
kinetic da ta  w as th en  used  to define the pharm acolog ical profile of th e  
ch lo rid e-d ep en d en t up take  system. The second phase of the study  tested the  
hypo thesis tha t the ch lo ride-dependen t u p tak e  system  is over-expressed in  
tu m o u r cell lines of glial origin. U sing  the p rev iously  de te rm ined
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pharm acological profiles to ensure specificity, several rat and  h u m an  cell 
lines w ere assayed for uptake activity. The last phase of the study  directly 
tested the hypothesis that transport system  th a t m ediated  the h igh-affin ity , 
ch lo ride-dependen t uptake of L-glutam ate into the gliom a cells shares 
identity  w ith  the cystine-glutam ate exchanger, system  xc. This was 
accom plished by sub-cloning xCT and 4F2hc from  a m ouse brain  cD N A  
library and  characterising the resu lting  activ ity  in a X enopus  oocytes 
expression system . The pharm acological profile  of this ch lo ride-dependen t 
transport w as then  com pared  w ith that of the  activated m ouse m acrophages 
expressing xCT and  4F2hc.
R e p ro d u c e d  with perm iss ion  of th e  copyright ow ner.  F u r th e r  reproduction  prohibited without perm iss ion .
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Specific Aims
The specific aim s of this project are to:
1) Q uantify the levels of expression , the kinetic p roperties  and  th e
pharm acological specificity of ch lo ride-dependen t, L -g lu tam ate  tran spo rt in to  
LRM55 cells.
2) Develop a pharm acological profile for this system  and  ascertain  if it is 
d istinct from  the w ell characterised  high-affinity, so d iu m -d e p e n d e n t 
transporters.
3) Com pare the kinetic and  pharm acological p roperties of the  ch lo ride- 
dependent, L -glutam ate tran spo rt system  w ith the p rev io u sly  iden tified  
cystine-glutam ate exchanger, system  xc .
4) Q uantify the in v itro  levels of activ ity  and  the pharm acological specificity 
of ch lo ride-dependen t, L -glutam ate tran sp o rt in a series of rat and  h u m a n  
glial tum our cell lines.
5) Clone xCT and  4F2hc from  a m ouse brain library an d  verify sequence
hom ology w ith  the xCT an d  4F2hc clones isolated from  m ouse m acrophages.
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6) Pharm acologically  characterise the m ouse brain-derived  clones in the  
Xenopus laevis oocytes expression system  in o rder to de term ine  it's 
rela tionsh ip  w ith  the high-affin ity  ch lo ride-dependen t, L-glutam ate transport 
system .
R e p ro d u c e d  with perm iss ion  of th e  copyright ow ner.  F u r th e r  reproduction  prohibited without perm iss ion .
C hap ter 2: M ethods and Materials
Cell Culture
LRM55 gliom a cells w ere grow n in H am 's  F-12 m edium  (pH 7.4) w ith  
Shain 's m odification  (Personal com m unication , W illiam  Shain). H am 's F-12 
m ed ium  w as m odified  to contain a final concen tra tion  (mM) of: L -alanine 
(0.2), L-arginine (2.0), L-asparagine (0.17), L-aspartic acid (0.2), L-cysteine (0.4), 
L-glutam ic acid (0.2), L-glutam ine (2.0), L-glycine (0.2), L-histidine (0.2), L- 
isoleucine (0.06), L-leucine (0.2), L-lysine (0.4), L -m ethionine (0.06), L- 
pheny la lan ine  (0.06), L-proline (0.6), L -serine (0.2), L -threonine (0.2), L- 
tryp tophan  (0.2), L-tyrosine (0.06), L-valine (0.2). In  addition the m ed ia  
included (final concentration), 75 p.M ascorbic acid, 2.0 mM pyruvate, 11 m M  
glucose, 5 mM  KC1, 0.85 mM MgCh, 0.15 m M  M gS 04, 2 mM CaCl,, 0.5 p.M 
Z n S 0 4 and  23.5 m M  N aH C 0 3. The culture m ed ia  w as supplem ented  w ith  5% 
foetal calf se rum  and a m ixture of pen ic illin  (100 U /m l) , streptom ycin (100 
(ig /m l) and  fungizone (0.1 fig/m l). U-373 and  U-87 gliom a cells were grow n in 
M inim um  Essential M edium  (pH 7.4) con ta in ing  1 m M  pyruvate and 16 m M 
N a H C 0 3 an d  supplem ented  w ith 10% foetal calf serum . SNB-19 gliom a cells 
w ere grow n in H am 's F-10 m edium  (pH 7.4) con ta in ing  13 mM  N aH C 0 3 and  
supp lem en ted  w ith  15% foetal calf serum . CCF-STTG1 glioma cells w ere 
grow n in RPMI m edium  1640 (pH 7.4) con ta in ing  25 mM D-glucose, 1 m M 
pyruvate  and  16 mM N aH C 03 and supp lem en ted  w ith  10% foetal calf se ru m .
13
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All cell lines w ere  cu ltu red  in 150 cm 2 flasks (C orning) and  m a in ta in e d  
at 37 °C in  a h u m id ified  a tm osphere  of 5% CO,. Cells w ere lifted from  th e  
flasks by the add ition  of trypsin  (0.25% final concentration) for 3-5 m in u tes  at 
37 °C for passage every  seven  days. A t th is tim e cell cu ltu re  stocks for cryo- 
p reserva tion  w ere p repared  by m ain ta in in g  lxlO6 to 2x l06 cells in th e  
app rop ria te  cu ltu re  m ed ia  su pp lem en ted  w ith  10% DMSO and  sto ring  at -196 
°C u n der liquid  N 2. For in d iv id u a l experim ents, cells w ere seeded in 12 w ell 
culture p lates (Costar) a t a density  of 5x l04 cells/w ell an d  m ain ta ined  for 5 to 8 
days un til ju st confluent. O nly passages betw een #7 an d  #20 w ere  u tilised  i n 
the presen t study. Cells form ed a confluen t m onolayer w ith  an  estim ated  
density of 2.5xl06 cells and  a p ro te in  concentra tion  of 100-350 p.g/well. Cells 
w ere given the  ap p ro p ria te  fresh m ed ium  tw o hours p rio r to an  assay.
Cell Transport Assay
The up take  of g lu tam ate  into cu ltu red  cells w as quan tified  using  a 
m odification  of the p rocedure  described by M artin  and  Shain, (1979). 
Ind iv idual w ells, after rem oval of cu ltu re  m edia, w ere rinsed  th ree  tim es and  
pre-incubated  in 1 m l HEPES buffered (pH  7.4) H ank 's balanced sa lt so lu tio n  
(HBHS) a t 30 °C for 10 m in. W here indicated, the HBHS w as a ltered  by ionic 
substitu tion  to isolate the Na* and  C1‘ -dependen t tran sp o rt system s. T he 
buffers con tained , (1) Total (Na~ and  C1‘ -dependent): 137 mM  NaCl, 5.1 m M  
KC1, 0.77 m M  K H 2P 0 4, 0.71 m M  M gS 04.7H20 ,  1.1 m M  CaCl2, 10 m M  D-
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glucose, 10 m M  HEPES; (2) N a~-dependent: 130 m M  N a gluconate, 5 m M  
K gluconate, 1.1 mM  Ca gluconate, 0.77 mM KH2P 0 4, 0.71 mM  M gS 04.7H ,0, 
10 mM  D-glucose, 10 m M  HEPES an d  (3) C l'-dependent: 137.5 mM  C holine Cl, 
5.36 mM KC1, 0.77 m M  K H 2P 0 4, 0.71 mM M gS04.7H 20 ,  1.1 mM CaCl2, 10 m M  
D-glucose, 10 m M  HEPES. U ptake was in itia ted  by asp ira tion  of the  
p reincubation  buffer an d  the  ad d itio n  of a 500 (il a liq u o t of the appropria te  
transport buffer con ta in ing  [3H ]-L-glutam ate (10-500 pM, final concen tra tion). 
In those assays that evaluated  inh ib ito r activity, the  500 pi a liquot of tran sp o rt 
buffer contained  both the  [3H ]-L-glutam ate and  p o ten tia l inhib ito rs to en su re  
sim u ltaneous addition . Follow ing a 5 m in incubation  at 30 °C, the assays 
were term inated  by th ree  sequential 1 ml w ashes w ith  ice cold buffer and  then 
the cells w ere disso lved  in  1 ml of 0.4 M N aO H  for 24 h o u rs . A n a liquot (200 
pi) was then  transferred  in to  a 5 m l glass sc in tilla tio n  vial and n eu tra lised  
w ith  the add ition  of 5 pi glacial acetic acid follow ed by 3.5 ml Liquiscint@  
scin tilla tion  fluid (N ational Diagnostics) to each sam ple . Incorpora tion  of 
radioactivity  w as quan tified  by liqu id  scintillation co u n tin g  (LSC, Beckman LS 
6500). Values reported  are corrected for non-specific up take  (e.g., leakage and 
binding) by subtracting  the a m o u n t of [3H ]-L-glutam ate accum ulation  at 4 °C. 
Protein con ten t was de te rm in ed  by  the b icinchonin ic  acid (BCA) m eth o d  
(Pierce) (Sm ith et al., 1985). K inetic constants of substra tes and inh ib ito rs  
w ere determ ined  using  th is sam e procedure by v ary ing  the concentrations of 
L-glutam ate and  inh ib ito rs w ith  respect to Km and  K, va lues (for review  see: 
C hristensen, 1975).
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Western Blot Analysis
LRM55 gliom a w hole cell hom ogenates w ere prepared  (m otorised  
W heaton  Potter-E lvejhem  T eflon/g lass) in ice cold hom ogen isa tion  buffer 
containing: 20 m M  Tris-HCl (pH  7.4), 10% (w /v ) sucrose, 1 mM  EDTA, 5 m M  
EGTA, 20 U /m l ap ro tin in , 20 M-g/ml leupep tin , 20 p.g/ml antipain , 0.1 m M  
PMSF and  10 m M  benzam idine. P ro te in  concentra tion  was dete rm ined  by’ 
BCA m ethod. A liquots of LRM55 hom ogenate  (5-10 p.g of protein) w ere 
d ilu ted  1:1 in Laem m li reducing  sam ple buffer (LSB) and  heated a t 95 °C for 3 
m in. Each sam ple  aliquot was subjected to SDS-polyacrylam ide gel 
e lectrophoresis (SDS-PAGE) on a 7.5% polyacrylam ide gel accom panied by 
m olecular w eigh t m arkers (Bio Rad) a t 15-25 m A  constant cu rren t and  
electroblotted to nitrocellose by e lectrophoretic  transfer at 200 m A co n stan t 
curren t overn igh t by  the m ethod of T ow bin et al., (1979). Protein bands w ere 
visualised by sta in ing  w ith  Ponceau S to confirm  com plete transfer. T he 
nitro-cellulose b lo t w as sectioned in to  in d iv id u a l sam ple lanes and these  
w ere blocked in blocking buffer, T ris-buffered saline (TBS) consisting of 1% 
non-fat m ilk, 0.1% Tween-20, 200 m M  N aCl in 50 mM Tris (pH 7.4) for 2 
hours at room  tem peratu re . Ind iv idua l lanes w ere then incubated w ith  
affinity purified  anti-G LTl, anti-GLAST and  anti-EA A Cl antibody d ilu ted , 
respectively, to 0.012 p g /m l, 0.12 n g /m l, or 0.44 p g /m l in blocking buffer for 1 
hou r afterw hich they were w ashed w ith  blocking buffer 5 tim es for 5 m in . 
The n itro-cellu lose strips w ere then  incubated  w ith  horseradish  peroxidase-
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conjugated donkey anti-rabbit IgG (1:5000 in blocking buffer) and  finally  
w ashed 5 tim es for 5 m in w ith  TBS. The im m unoreac tive  p ro te ins w ere 
v isualised  w ith  enhanced chem ilum inescence  (A m ersham ).
R N A  Isolation and Expression in Xenopus laevis Oocytes
LRM55 glioma cell RNA w as iso lated  by using  T R Iz o l®  R eagent (Life 
Technologies), an im provem en t on  th e  m ethod  of C hom czynski and  Sacchi 
(1987) and  poly (Ap enriched by u tilis ing  a O ligotex mRNA M ini Kit (Qiagen) 
according to m anufacturers in structions. m R N A  (50 ng) was injected in to  
defolliculated stage V or VI X enopus  oocytes. T ransport activity  w as assayed 
as described below.
cDNA Cloning, Plasmid Construction and Sequence Analysis 
>
The am ino acid sequences o f xCT, (Sato et al., 1999) and 4F2hc 
(Parm acek et al., 1989) w ere ob tained  from  the GenBank Database (accession 
no. AB022345 and X14309 respectively). The coding sequences of xCT and  
4F2hc w ere isolated from  cDNAs by the polym erase chain reaction (PCR). 
Thirty-five cycles of denatu ration  (30 sec, 94 °C), annealing (40 sec, 56 °C), and  
extension (80 sec, 72 °C) w ere p e rfo rm ed  in  50 jil reactions th a t con ta ined  
synthetic oligonucleotide p rim ers a t 0.2 (xM each, 10 ng of p lasm id  cDNA 
tem plate, 200 p.M each deoxynucleotide, 2.5 U Taq polym erase and  reaction
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buffer (New England Biolabs). U nique flanking restric tion  sites (EcoR I and  
Xba I for xCT and H in d  HI an d  Xba I for 4F2hc) w ere in co rp o ra ted  into the  
oligonucleotide prim ers. P rim er sequences (5' to 3') w ere: AA A  GAA TTC 
ATG GTC AGA AAG CCA GTT GTG and  AAA TCT A G A  ATA ATT CTT 
TAG AGT CTT CTG for xCT, a n d  AAA AAG CTT ATG A G C CAG GAC ACC 
GAA and  AAA TCT AGA TCA GGC CAC AAA GGG G A A  CTG for 4F2hc. 
D igestion of the reaction p ro d u cts  w ith  the appropria te  res tric tion  enzym es 
allow ed each coding sequence to  be subcloned into expression  plasm ids.
The PCR-generated coding  sequences w ere subc loned  into th e  
expression plasm id pO G l for xCT and pBlueScript II, pBSKII(-), for 4F2hc to 
generate constructs (term ed  pO G l-xCT and pBSK-4F2hc) for expression in  
Xenopus laevis oocytes. p O G l is a vector derived from  pBSTA that contains a 
m u ltip le  cloning site be tw een  flanking Xenopus  (3-globin 5 '-un transla ted  
sequence and 3'-poly(A) signal regions derived from  pSP64T to enhance 
expression levels in oocytes. The pBSKII(-) vector (S tratagene) was utilised 
due to lack of incorporation  of 4F2hc coding sequences into p O G l. The coding 
sequences in the pO G l-xCT an d  pBSK-4F2hc p lasm ids w ere  confirm ed  by, (1) 
sequencing on both  s tran d s by the dideoxy chain te rm in a tio n  m ethod  using 
T7 and T3 synthetic o ligonucleo tide  prim ers and  (2) restric tion  enzym e 
m apping .
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Expression o f  xC T and 4F2hc in Xenopus laevis Oocytes
Capped R N A  w as transcribed in vitro  from  linearised  (Not  I) pO G l- 
xCT and pBSK-4F2hc constructs sim u ltaneously  using  T7 polym erase as 
described by K avanaugh  e t al., (1992) and injected in to  defolliculated stage V 
or VI Xenopus  oocytes (approxim ately  1-50 ng /oocy te). Two to seven days 
follow ing in jection, tra n sp o rt w as assayed by p lac ing  in d iv id u a l oocytes in  
Na* free R inger's so lu tio n  consisting  of 96 mM choline Cl, 2 m M  KC1, 1.8 m M 
CaCl2, 1 mM M gCl2 a n d  5 m M  HEPES (pH 7.5) co n ta in in g  [3H]-L-glutam ate (1- 
500 (iM, final concentra tion). In those assays tha t ev a lu a ted  inh ib ito r activity, 
the transport buffer con ta ined  both the [3H ]-L -glutam ate and  inhibitors to 
ensure s im u ltan eo u s ad d ition . Follow ing a 30 m in  incubation  at 20 °C, the  
assays were te rm in a ted  by th ree  sequential 2 m l w ashes w ith  fresh Na* free 
Ringer's so lu tion  and  then  the oocytes were d isso lved  in  500 p.1 of 10 % SDS 
for 1 hour in a 5 m l glass sc in tilla tion  vial follow ed by the  add ition  of 3.5 m 1 
Liquiscint@ sc in tilla tion  fluid (N ational D iagnostics) to each oocyte. 
Incorporation of rad ioactiv ity  w as quantified by liqu id  scin tilla tion  coun ting  
(LSC, Beckman LS 6500). V alues reported  are corrected for non-specific 
uptake (e.g., leakage an d  binding) by sub tracting  the am o u n t of [3H]-L- 
glutam ate accum ulation  in H 20  injected oocytes.
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Materials
LRM55 gliom a cells were ob tained  from  the laboratory of D avid M artin  
(W adsw orth  C entre, Albany, NY) w here  the line w as developed. U-373, U-87, 
SNB-19 an d  CCF-STTG1 gliom a cell lines w ere purchased  from A m erican  
Type C u ltu re  Collection (ATCC) (M anassas, VA). G eneral cell culture supplies 
w ere purchased  from  Becton D ickinson (Franklin  Lakes, NJ), C orn ing  
(Com ing, NY), and  Life Technologies (G rand Island, NY). L-[3,4-3H]-Glutam ic 
acid was purchased  from D upont N E N  (Boston, MA). L-Glutam ate, L-cystine, 
L -a-am inoadipate , D-aspartate, d ihydrokainate , kainate, L-homocysteate, L- 
hom ocysteine su lph inate  and  L -serine-O -sulphate w ere purchased  from  
Sigma (St. Louis, MO). (R S)-4-brom ohom oibotenate, quisqualate, ibotenate, 
L-(3-ODAP, AP4, NM DA and A M PA  w ere purchased  from  Tocris (Ballw in, 
MO). (1S,3S)-1,3-homo-ACPD w as ob tained  from  K enneth  Curry. 2,4-MPDC, 
L-frans-2,4-PDC, L-frrms-2,3-PDC an d  L-anti-endo-3,4-MPDC were synthesised  
as described (Bridges et al., 1991; Bridges et al., 1993; Bridges et al., 1994; 
H um p h rey  et al., 1994; Esslinger e t al., 1998). GLAST, GLT-1 and  EAAC1 
antibodies w ere provided  by Jeffery Rothstein. G eneral m olecular biology 
supplies and  kits w ere purchased  from  N ew  England Biolabs, Prom ega 
(M adison, WI), Q iagen (Valencia, CA) and  Stratagene (La Jolla, CA). All o th e r 
chem icals w ere purchased  from  Sigm a (St. Louis, MO).
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Chapter 3: Pharmacology o f H igh-A ffinity, L-Glutamate Transport in  LRM55 
Gliom a Cells. 
Introduction
Studies of L-glutam ate transport w ith in  the CNS have  em ployed a 
w ide n u m b er of experim ental p repara tions, including: synap tosom es,
synaptic vesicles and neuronal and  glial cell cultures. C om parisons of the  
pharm acological specificity, ionic dependence , cell type an d  subcellu lar 
localisation w ith in  such p repara tions have  confirm ed the existence of severa l 
distinct EAA transport proteins. The focus of the m ajority of the  stud ies has 
centred  on  the sod ium -dependen t, h igh-affin ity  system s, consequen tly  they 
are the m ost thoroughly  characterised  in regard to pharm aco logy , 
d istribu tion , m echanism  and  m olecular b io logy  (for review  see: G e le lash v ili 
and  Schousboe, 1999). The syn thesis of conform ationally  constra ined  
analogues based on  L-glutam ate and  L -aspartate has a llow ed  tran sp o rte r  
subtypes to be differentiated and  p h a rm aco p h o re  m odels for each to be 
developed  (Bridges et al., 1999), w h ilst the generation  of an tibod ies has 
enabled the cellular and regional d istribu tions of transporters to be v isu a lised  
(R otnstein e t al., 1994; Furuta et al., 1997; Sw anson et al., 1997). C loning  and  
subsequen t expression of the so d iu m -d ep en d en t, h igh-affin ity  tran sp o rte rs  
has allow ed their biophysical na tu re  to be  p robed  and led to the d iscovery  of a 
new  transporte r gene family (Arriza et al., 1993; Arriza et al., 1994; Fairm an et
21
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al., 1995; A rriza et al., 1997). Such advances have established  the p ro m in e n t 
role w h ich  this system  plays in  both  no rm al synaptic tran sm iss io n  and  in  
d isease processes in the CNS (Choi, 1988).
M ore recently, a tten tio n  has focused on ch lo ride-dependen t, h igh- 
affinity L -glutam ate tran sp o rt system s th a t are distinct from  the so d iu m - 
d ep en d en t system s in term s of pharm acology, d istribu tion  a n d  m ech an ism . 
M uch of o u r know ledge regard ing  ch lo ride-dependen t L -glu tam ate up take  
has resu lted  from  stud ies u tilising  the LRM55 gliom a cell line, as these cells 
no t on ly  express the so d iu m -d ep e n d en t system , b u t exhibit m arked ly  greater 
am o u n ts  of ch lo rid e -d ep en d en t tran sp o rt activity than  p rim a ry  astrocyte 
cu ltu res. L -G lutam ate up take  a ttribu tab le  to the action of the so d iu m - 
d ep en d en t system s w as de te rm in ed  to account for 65 % of the total L- 
g lu tam ate  u p tak e  w hile  ch lo rid e-d ep en d en t uptake w as fo u n d  to co n stitu te  
35 % of this total. It w as also show n  tha t L-glutam ate up take  via the ch lo ride- 
dep en d en t system  w as unaffected by the presence of L -aspartate, L-cysteate and 
L-cysteine su lph ina te , know n inh ib ito rs of the so d iu m -d ep en d en t system s 
(W aniew ski and  M artin , 1984). A lthough  these initial in v es tig a tio n s 
confirm ed  the  presence of ch lo rid e-d ep en d en t transport in  the  cells, they 
failed to in d iv id u a lly  characterise the system s in term s of kinetics o r  
pharm acology . Further, the pharm acolog ical characterisation of the ch lo ride- 
d e p en d en t up tak e  w as incom plete, as no specific inhib ito rs w ere identified . 
The w o rk  p resen ted  in  th is chap ter deta ils the characterisa tion  of the ionic
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dependency and  pharm acological specificity of the h igh-affin ity  L-glutam ate 
transport system s in  LRM55 gliom a cells.
Results and D iscussion
Ionic dependence o f L-glutamate transport in LRM55 glioma cells
The up take  of [3H ]-L-glutam ate into LRM55 cells w as evaluated  u n d e r 
various ionic cond itions (Table 3.1). The con tribu tion  of so d iu m -d ep en d en t 
and ch lo rid e-d ep en d en t tran sp o rt system s to total L -glutam ate uptake was 
determ ined  and  the  pharm acological character of each of the sites was 
indiv idually  resolved. In the presence of both sod ium  and chloride ions the  
rate of up take of L -glutam ate (100 p.M) was 374 ± 14 p m o l/m in /m g  protein . 
Kinetic analysis of total L -glutam ate uptake in LRM55 gliom a cells is show n  
in Figure 3.1. The rep resen ta tive  L inew eaver-B urk p lo t dem onstrates the  
uptake of L -glutam ate in the presence of sod ium  and  chloride. The Km and 
Vmax values for th is p a rticu la r experim ent w ere found  to be 52 ± 15 pM and  
524 ± 66 p m o l/m in /m g  p ro tein , respectively. The average of six such  
determ inations resu lted  in an average Km value of 63 ± 3 p.M and Vmax va lue  
of 498 ± 22 p m o l/m in /m g  pro tein . This value is sim ilar to the previously  
determ ined  Km value  of 123 p.M in this cell line (W aniew ski and  M artin, 
1984), though  the Vmax reported  (2.99 n m o l/m in /m g  protein) is approxim ately 
eight-fold larger, suggesting  a reduced capacity to tran spo rt L-glutam ate u n d er
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the present assay conditions. R em oval of both sodium  and  ch loride ions 
(equim olar substitu tion  w ith  sucrose) produced a rate of on ly  22 ± 3 
p m o l/m in /m g  p ro tein , an  am o u n t w hich represents 6 % of to ta l transport. 
This rate is com parable to the non-specific uptake (e.g., leakage and  binding) 
(17 ± 2 p m o l/m in /m g  protein) that w as determ ined  by quan tify ing  uptake at 
4 °C.
Sodiian-dependent uptake in LRM 55 glioma cells
Uptake of L-glutam ate decreased to 239 ± 11 p m o l/m in /m g  p ro tein  
w hen  gluconate w as substitu ted  for chloride. The con tribu tion  of sod ium - 
dependent transport to total L -glutam ate flux (i.e. uptake in  the presence of 
sod ium  and chloride) in LRM55 cells was calculated to be 65 %, a value that 
agrees w ith p rev ious reported data (W aniew ski and M artin, 1984). Kinetic 
analysis of sod ium -dependen t L-glutam ate uptake is show n in Figure 3.2. 
The representative L inew eaver-B urk plot illustrates the up take  of g lu tam ate 
in the presence of sod ium  and the absence of chloride (gluconate 
substitution). The Km and V max values for this particular experim en t were 
found to be 60 ± 33 jaM  and 323 ± 82 p m o l/m in /m g  protein, respectively. The 
average of tw elve such determ inations resulted in a m ean Km va lue  of 58 ± 5 
uM and Vmax of 365 ± 16 p m o l/m in /m g  protein. The Km v a lu e  for L- 
glutam ate up take in these cells is consistent w ith  the reported  range (30-90 
p.M) for glial cells (Hertz et al., 1978; G arlin et al., 1995; Dowd et al., 1996).
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Chloride-dependent uptake in LRM55 glioma cells
The replacem ent of sod ium  w ith  lith iu m  decreased up take  to 168 ± 12 
p m o l/m in /m g  p ro tein , w hile rep lacem ent of so d iu m  w ith  choline  fu rth e r  
reduced  the  rate of up take  to 119 ± 7 p m o l/m in /m g  pro tein . The p ro p o rtio n  
of to tal transport a ttribu tab le  to the ch lo ride-dependen t system  w as found  to 
be 45 % and  32 % w ith  the rem oval of sod ium  by lith iu m  and  by cho line, 
respectively  (Table 3.1). Kinetic analysis of ch lo rid e-d ep en d en t L -glu tam ate 
up take  is show n in Figure 3.3. The rep resen ta tive  L inew eaver-B urk  p lo t 
illu stra tes the up take  of g lu tam ate  in the presence of ch loride w ith  cho line  
su b stitu tin g  for sod ium . The Km and V max va lues for this p a rticu la r 
experim en t w ere found  to be 66 ± 2 |x.M and  131 ± 2 p m o l/m in /m g  p ro te in , 
respectively. The average of fourteen  such d e te rm in a tio n s resu lted  in an  
average Km value of 54 ± 3 jiM  and  a Vmax value  of 169 ± 6 p m o l/m in /m g  
pro tein . These resu lts indicate that both  the sod ium - and  c h lo rid e -d ep en d en t 
system s have sim ilar affinities for L-glutam ate in the LRM55 gliom a cells.
Pharmacology of sodium-dependent uptake in LRM 55 glioma cells
To determ ine  the subtypes of so d iu m -d ep en d en t transporte rs p resen t 
in the LRM55 cells, the pharm acology w as eva lua ted  under ch loride-free  
cond itions w ith  L -glutam ate analogues know n for the ir ability block up take  
th ro u g h  GLAST/EAAT1, GLT-1/EAAT2 and  EAAC-1/EAAT3. C on tro l
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values, i.e., the rate of up take in the absence of inhibitor, w ere fo u n d  to be 239 
± 11 p m o l/m in /m g  protein. W hen included  in the assay a t 500 (iM (Table
3.1), u p tak e  w as decreased to 24 ± 1 % of C ontro l w ith  L-trans-2,4 -pyrro lid ine  
dicarboxylate (L-frrms-2,4-PDC), bu t on ly  70 ± 1 % of C on tro l w ith  
d ih y d ro k a in a te  (DHK). The inh ib ition  of sod iu m -d ep en d en t tran sp o rt by L- 
frans-2,4-PDC and  the relative insensitiv ity  of transport to DHK, suggests th is  
up take  is m ed iated  by GLAST/EAAT1 o r EAAC-1/EAAT3. W estern  blot 
analysis of LRM55 cell hom ogenates p roduced  im m unoreac tiv ity  to GLAST, 
bu t no t to GLT-1 and EAAC1, con firm ing  the expression of GLAST on th e  
LRM55 g liom a cells (Figure 3.4).
Pharmacology o f chloride-dependent uptake in LRM55 glioma cells
EAA analogues were system atically  assayed as po ten tial inh ib ito rs of 
the ch lo rid e-d ep en d en t system . In these experim ents so d iu m  w as replaced 
w ith  choline. C ontrol levels of [3H ]-L -glu tam ate  uptake in  the  absence of any  
added  analogues w ere found to be 119 ± 7  p m o l/m in /m g  pro tein . W hen 500 
p.M L -glu tam ate w as included in the assay, up take was reduced to 26 ± 3 % of 
C ontrol. P o ten t inh ib ito rs w ere d istingu ished  by their ability  p roduce  a n  
inh ib ition  sim ilar to o r greater than  500 fiM L-glutam ate.
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E A A  receptor agonists
The EAA receptor agonists NM DA (90 ± 3 % of Control), AM PA (95 ± 2 
% of C ontrol), kainate (91 ± 2 % of Control) and  L-AP4 (91 ± 4 % of C ontrol) 
d id  no t significantly  reduce the ch loride-dependent L-glutam ate up take (Table
3.2).
High affinity, sodium-dependent L-glutamate transport inhibitors
Both D- and L-aspartate, w hich  serve as substrates of the so d iu m - 
d ep en d en t transporters, d id  no t com petitively  block L-glutam ate up take  by 
the ch lo ride-dependen t transporters (98 ± 1 and  96 ± 3 % of C ontrol, 
respectively). A library of pyrro lid ine  dicarboxylate analogues w hich  h ave  
been used to define the pharm acophores of the so d iu m -d ep en d en t 
tran spo rte rs  w ere also assessed for cross-reactivity w ith the chloride- 
d ep en d en t system . DHK (100 ± 0 % of Control), L-trans-2,4-PDC (93 ± 3 % of 
C ontrol), L-tfnff-endo-3,4-MPDC (100 ± 0 % of Control), 2,4-MPDC (97 ± 3 % of 
Control) an d  L-trans-2,3-PDC (93 ± 3 % of Control) d id  no t m arkedly a ttenua te  
the influx of L-glutam ate into the LRM55 gliom a cells under sod ium -free  
conditions (Table 3.2).
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L-Glutamate vesicular transporter inhibitors
A series of qu ino line  analogues that con ta in  a rigid bicyclic m o lecu lar 
fram ew ork, have  been  show n to possess considerable inh ib ito ry  activity  at the 
L-glutam ate vesicu lar transporter (Carrigan et al., 1999; Bartlett et al., 1998; 
Fyske et al., 1992). W hen tested against ch lo rid e-d ep en d en t uptake, 
kynurenate  (89 ± 2 % of Control), 7 -chloro-kynurenate  (90 ± 2 % of C ontrol), 
xan thurenate  (90 ± 2 % of Control) and  2 ,4-quinoline dicarboxylate (2,4-QDC) 
(90 ± 1 of C ontrol) had  little or no effect on  the up take  of [3H]-L-glutam ate 
(Table 3.2).
L-Cystine and L-cysteine analogues
L-Cystine is a dicarboxylic am ino acid th a t has been show n to a ttenuate  
ch lo ride-dependen t L-glutam ate b ind ing  in au to rad iog raph ic  studies and 
ch lo ride-dependen t up take in cell transport s tud ies (A nderson  et al., 1990; 
Bridges et al., 1987). In the  presen t w ork, L-cystine potently  inhib ited  the 
ch lo ride-dependen t up take of [JH]-L-glutam ate (100 p.M) into LRM55 gliom a 
cells (22 ± 3 % of Control) w hen included in the assay at 500 fiM (Table 3.3). A 
m ore deta iled  kinetic analysis of the action of L-cystine is depicted in Figure 
3.5. The rep resen ta tive  L inew eaver-B urk p lo t is consisten t w ith  the activity 
of a com petitive inhibitor, i.e., increasing concentrations of the inhib itor yield 
increased values for Kmapp, w ith  no change in Vmax. The Km and Vmax values
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm issio n .
for the tran sp o rt of [3H ]-L -glutam ate w ere found to be 62 ± 7 pM and  323 ± 21 
p m o l/m in /m g  p ro te in , respectively. A slope replo t (Figure 3.5 inset) of the  
Kmapp values y ie lded  a Kt va lue  of 48 ± 7 pM for this p a rticu la r experim en t, 
and the average  of five such  de term ina tions resu lted  in an  average K, v a lu e  
for L-cystine o f 49 ± 7 pM (Table 3.4).
The red u c tio n  of L-cystine yields the am ino  acid L-cysteine. W hen L- 
cysteine w as tested  a t the ch lo ride-dependen t up take  site, it exhibited no  
inhibitory effect (99 ± 2 % of Control). A n um ber of ana logues based on the  
structures of L-cystine and  L-cysteine were also ev a lu a ted  for activity. L- 
Cysteate and  L-cysteine su lph inate  induced  little in h ib itio n  (86 ± 6 and 89 ± 5 
% of C ontro l, respectively; Table 3.2), w hilst the longer chain  analogues L- 
hom ocysteate (21 ± 3 % of C ontrol) and  L-hom ocysteine su lp h in a te  (33 ± 2 % 
of Control) d isp layed  a sim ilar activity as tha t of L-cystine (Table 3.3). S- 
Carboxym ethyl-L-cysteine and  S-carboxyethyl-L-cysteine also potently  
inhibited u p tak e  (36 ± 0.3 and  55 ± 3 % of C ontrol, respectively). Several L- 
cystine analogues p roduced  little inh ib ition  of ch lo rid e-d ep en d en t up take 
including: D -cystine (94 ± 3 % of Control), D ,L-hom ocystine (79 ± 3 % of 
Control) and  L-djenkolate (88 ± 2 % of Control). In  contrast, L -cysthath ionine 
and D ,L -raeso-lan th ion ine exhibited  m oderate  inh ib ito ry  activity  (62± 2 and 
63 ± 2 % of C ontro l) (Table 3.3).
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Isoxazole analogues
Several isoxazole analogues based on the structure  of ibotenic acid 
have been  dem onstra ted  to inh ib it ch lo ride-dependen t b ind ing  (A nderson  et 
al., 1990; Bridges et al., 1986). Three analogues, ibotenate, L-quisqualate and  
(R S)-4-brom ohom oibotenate w ere assayed for activity in the LRM55 cells at 
the ch lo rid e-d ep en d en t transporter. The order of potency as de te rm ined  by 
the observed  levels of inh ib ition  was: L-quisqualate (1 ± 0.4 % of C ontrol), 
(R S)-4-brom ohom oibotenate (7 ± 1 % of Control) and  ibotenate (20 ± 1 % of 
C ontrol) (Table 3.3). A t 500 |xM, L-quisqualate produced an a lm ost com plete  
inh ib ition  of up take  of [3H ]-L -glutam ate into LRM55 gliom a cells. The resu lts 
of m ore deta iled  studies of the inhib itory  action of L-quisqualate as a function  
of concen tra tion  are show n in F igure 3.6. The L inew eaver-B urk p lo t displays 
the characteristic  pa ttern  of inhib ition  observed w ith a com petitive  inh ib ito r, 
Km an d  V max values w ere de te rm ined  to be 61 ± 8 p.M and  70 ± 5 
p m o l/m in /m g  protein , w hile the rep lo t of the Kmapp generated a K, value of 4 
± 2 (J.M. The average of three sim ilar experim ents produced a m ean  K, v a lu e  
of 5 ± 3 (iM (Table 3.4). Sim ilarly, a L inew eaver-B urk plot and rep lo t of Kmapp 
vs in h ib ito r concentra tion  (inset) for (R S)-4-brom ohom oibotenate is sh o w n  
in F igure  3.7. The pa ttern  of in h ib itio n  observed in this analysis was also 
consisten t w ith  com petitive  in h ib itio n  and  yielded Km, V max and  Kt values of 
44 ± 2 p.M, 58 ± 1 p m o l/m in /m g  p ro te in  and  18 ± 4 p.M, respectively. T hree  
such analyses yielded an  average K, of 18 ± 4 |j.M (Table 3.4).
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Other active analogues
Several o ther L-glutam ate analogues displayed activity at the LRM55 
ch lo ride-dependen t site. N otably, L -a-am inoadipate, w hich  contains a n  
ad d itio n a l m ethylene m oiety in its carbon backbone, d im in ished  transport to 
37 ± 2 % of Control. L-Serine-O -sulphate (L-SOS) also p roduced  a p o ten t 
inh ib ition  of [3H ]-L-glutam ate accum ulation  (12 ± 1 % of C ontrol), w hile the D 
enan tiom er w as found to be considerably  less potent (66 ± 2 % of Control). S- 
Sulpho-L-cysteine, w hich bears a considerable sim ilarity to L-SOS, also 
inhibited  up take (44 ± 3 % of Control). (5-N -O xalyl-L-a,p-diam inoproprionate, 
an excito toxin  involved in the aetiology of h u m an  neu ro la thy rism  (Spencer, 
1999), inhib ited  uptake to 34 ± 5 % of Control (Table 3.3).
These findings indicate that high-affinity  L-glutam ate transport in  
LRM55 cells appears to consist of at least two distinct system s, one so d iu m - 
d ep en d en t and  the other ch loride-dependent. The first, w hich accounts for 
65% of total transport, exhibits rem arkable sim ilarity to the well defined 
sod ium -dependen t, h igh-affinity  L-glutam ate system  GLAST. Thus, up take  
w as sensitive to inhibition by  L-trans 2,4-PDC, but not DHK. Further, w estern  
analysis confirm ed the expression of GLAST in the LRM55 cells. The second 
system  is dependen t on chloride and independen t of sodium . Ionic 
su b stitu tio n  of sodium  w ith  e ither lith ium  or choline was used  to isolate th is  
tran sp o rt m echanism . H ow ever, com parison  of the inhibitory effect of L-
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frans-2,4-PDC in the presence of e ither lith ium  o r choline, d em o n stra ted  
d ifferen t levels of inh ib ition , w ith  less activ ity  found  in the cho line- 
su b s titu tio n  experim ents. The reason  for this m ay  stem  from the ability of 
lith iu m  to drive, to som e sm all degree, sod iu m -d ep en d en t transport. 
C onsisten t w ith  this conclusion, lith ium  has been  show n capable of 
p roducing  ionic currents th ro u g h  these transporte rs  in  the total absence of 
sod ium  (unpub lished  data, K av an au g h  1999). To avo id  this com plication , 
later experim ents used only cho line  to replace sod ium . The kinetic analyses 
of bo th  system s reveal sim ilar affinities for L -glu tam ate in the range of 50 
p.M, w hich  correlates to the affin ity  for L -glutam ate transport in glial cell 
cu ltu res (D ow d et al., 1996). O n  the basis of the analogues assayed in Table 3.2 
and  3.3, it can  be concluded that the  L -glutam ate b in d in g  site on the ch lo ride- 
d ep en d en t transporte r is d istinc t from  other g lu tam ate  binding sites p resen t 
in the CNS. Thus, ch lo ride-dependen t L -glutam ate transport was unaffected 
by the w ell know n EAA receptor agonists N M D A , AMPA and kainate . 
Sim ilarly, no activity w as d em o n stra ted  by inh ib ito rs of the L -glutam ate 
vesicular transporter. Further, m any  of the  k now n  blockers of so d iu m - 
d ep en d en t transport proved  to be only w eak  inh ib ito rs at the ch loride- 
d ep en d en t site, suggesting a d istinc t p h a rm aco p h o re  for each protein(s). 
A nalogues that p roved  to be g rea ter than  or equal to L-glutam ate as inh ib ito rs  
of the ch lo ride-dependen t system  include: L-cystine, L-homocysteate, L- 
qu isquala te , (R S)-4-brom ohom oibotenate, ibo tenate , L -a-am inoadipate and L- 
serine-O -sulphate. Each of these analogues inh ib ited  uptake in a m a n n e r
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm issio n .
3 3
consisten t w ith  com petitive inhibition, suggesting  all are b ind ing  to the sam e 
site on  the ch lo ride-dependen t transporter.
Taken together, the resu lting  pharm acological profile ap p ea rs  to m irror 
a that of system  xc', a glutam ate-cystine exchanger (M urphy et al., 1989). B oth 
L -glu tam ate and  L-cystine serve as substra tes at this obligate exchanger. 
S im ilar to the ch lo ride-dependen t site, L -glu tam ate uptake by system  xc" has 
been  show n  to be potently  inhib ited  by L-cystine, L-quisqualate, L- 
hom ocysteate  an d  L -a-am inoadipate . The ability to discern w hether the  
ch lo rid e-d ep en d en t site on  the LRM55 cells and  the system  xc' are closely 
related  or the sam e uptake system  will d ep en d  upon  the d ev e lopm en t of a 
m ore ex tensive library of conform ationally  constra ined  inh ib ito rs and  the  
even tually  cloning of these transporters.
In sum m ary , the LRM55 gliom a cells p ro v id e  a m odel system  in w h ich  
to s tu d y  the pharm acology and  kinetics of h igh-affin ity , ch lo ride-dependen t 
L-glutam ate transport. Initial characterisations have identified  a library of 
analogues w hich  can be used to define the ch lo ride-dependen t substrate 
b in d in g  site. W hile num erous chem ical p ro p erties  m ay influence w hether or 
not a co m p o u n d  b inds the transport site, th is library could be u tilised in the  
design  of novel conform ationally  constra ined  analogues. Such analogues 
will be crucial to delineating  the p h a rm aco p h o re  for this transporter. T he 
increased levels of ch lo ride-dependen t u p tak e  activity in the LRM55 gliom a
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cells also m ake them  a po ten tia l source from  w hich to clone the  ch loride- 
d ep en d en t tran spo rt system. The isolation of m RN A  and  construction  of a 
LRM55 cD N A  library represen t possible steps in the even tual expression  
c loning of this transporter. The h igh levels of expression in the LRM55 
gliom a cells also h in ts at a possible association betw een glial tu m o u rs  and  
increased ch lo ride-dependen t uptake activity. This observation  w ill be of 
great im portance  in the follow ing chapter, as the pharm acological profile  
defined here w ill be used to characterise ch lo ride-dependen t tran spo rt in a 
variety  of glial tum our cell lines.
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Figure 3.1 Kinetic characterisation of [3H]-L-glutamate uptake into
LRM55 glioma cells in the presence of sodium  and chloride.
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R epresen tative  L inew eaver-B urk p lo t dem onstra ting  the up take o f [JH]-L- 
g lu tam ate  into LRM55 gliom a cells. U ptake w as quantified  in the presence of 
sod ium  and  chloride as described in M ethods and M aterials and  has been 
corrected for non-specific up take  and  leakage. The plo t show n  was generated  
using  the k-cat kinetic analysis p rog ram  (BioMetallics Inc, Princeton, NJ) w ith  
w eighting  based  on  constant relative error, and  yielded values of: Km = 52 ± 15 
and Vmax = 524 ± 66 p m o l/m in /m g  protein.
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Figure 3.2 Kinetic characterisation of [3H]-L-glutamate uptake into
LRM55 glioma cells in the presence of sodium.
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R epresen ta tive  L inew eaver-B urk  p lo t dem onstra ting  the u p tak e  of [3H]-L- 
g lu tam ate  into LRM55 gliom a cells. U ptake w as quantified  in the presence of 
so d iu m  w ith  gluconate su b s titu tin g  for chloride as described in M ethods and  
M aterials and  has been corrected for non-specific up take  an d  leakage. T he 
p lo t show n  w as generated  using  the k-cat kinetic analysis p rogram  
(BioM etallics Inc, P rinceton , NJ) w ith  w eighting  based on  constan t re la tive  
e rror, an d  yielded values of: Km = 60 ± 33 and V max = 323 ± 82 p m o l/m in /m g  
p ro te in .
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Figure 3.3 Kinetic characterisation of [3H]-L-glutamate uptake into
LRM55 glioma cells in the presence of chloride.
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R epresentative L inew eaver-B urk plot dem onstra ting  the up take of [3H]-L- 
g lutam ate into LRM55 gliom a cells. U ptake w as quantified  in the presence of 
chloride w ith  choline substitu ting  for sod ium  as described in M ethods and 
M aterials and  has been corrected for non-specific up take  and  leakage. The 
plot show n  w as generated using  the k-cat kinetic analysis program  
(BioMetallics Inc, Princeton, NJ) w ith  w eighting  based on constant relative 
error, and  yielded values of: Km = 66 ± 2 and  Vmax = 131 ± 2 p m o l/m in /m g  
p ro te in .
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Figure 3.4 Western blot analysis of high-affinity, sodium-dependent L-
glutamate transporters in the LRM55 gliom a cell line.
GLAST GLT-1 EAAC1
W estern blot analyses of whole cell hom ogenates prepared from LRM55 
gliom a cells w ith antibodies for the sodium -dependent, high-affini ty L- 
glutam ate transporters, anti-GLAST (0.12 ug /m l), anti-GLT-1 (0.012 ug /m l) 
and EAAC1 (0.44 ng /m l). Each lane contains approxim ately 10 ug of total 
protein. Im m unodetection was perform ed as described in M ethods and 
Materials.
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Table 3.2 Inactive EAA analogues at the high-affinity, chloride-dependent
[3H]-L-glutamate uptake site in LRM55 glioma cells._____________________
C o m p o u n d
N M D A
A M PA
K ainate
D,L-AP4 
D,L-AP3 
D -A spartate 
L-A spartate
D ihydrokainate
S tru c tu re
U ptake of IOOjiM 
3H -L -g lu tam ate  
(% of Control)
C O aH
h 3C \  ^ c o 2h
N —
H
OH
90 ± 3
95 ± 2
H3C- I
c h 2
c o 2h
a‘ (M C O ,H
H
91 ± 2
h o 2c P O (O H )2
h o 2c
NHo
h o 2c
P O (O H )2
c o 2h
C O ?H
H ,N
c o 2h
c h 3
H ,C x\\ c o 2h
c c‘ N C 0 2H 
H
91 ± 4
91 ± 5
98 ± 1
96 ± 3
100 ± 0
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U ptake o f IOOjiM 
:'H -L -g lu tam ate  
(% o f Control)
C o m p o u n d S truc tu re
L-frarcs-2,4-PDC 93 ± 3
L-flnfz-cndo-3,4-MPDC 100 ± 0
2,4-MPDC 97 ± 3
L-fnms-2,3-PDC 93 ± 3
OH
K ynurenate 89 ± 2
COOH
OH
7-C h lo ro -kynurenate 90 ± 2
COOH
OH
90 ± 2X an th u ren a te
OH
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U ptake of lOOpM 
3H -L -glu tam ate 
(% of Control)
C om p o u n d Structure
COOH
90 ± 1
COOH
L-Cysteine 99 ± 2
SH
L-Cysteate 86 ± 6
L-Cysteine su lph inate 89 ± 5
s o 2h
NH.
94 ± 3D-Cystine
79 ± 2D,L-Hom ocystine
C 0 2h
L-Djenkolate 88 ± 2
c h 2
97 ± 1O -Phospho-L-serine
h 2n '
98 ± 2O -Phospho-D -serine
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Table 3.2: LRM55 gliom a cell u p tak e  of [3H ]-L-glutam ate is rep o rted  as m e a n  
% of control ± S.E.M. The data  for each com pound w as based  on  a t least th ree  
dup lica te  determ inations from  sep ara te  experim ents. A verage contro l up take  
of [3H]-L-glutam ate in the cells w as 119 p m o l/m in /m g  p ro te in . The assays 
w ere  perform ed as described in  M ethods and M aterials an d  have been 
corrected for non-specific up take  an d  leakage.
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Table 3.3 Potent inhibitors of high-affinity, chloride-dependent, [3H]-L-
glutamate uptake in LRM55 glioma cells.
U ptake of 100(iM 
3H -L -g lu tam ate  
(% of Control)
C o m p o u n d S tru c tu re
L -G lutam ate 26 ± 3
L-Cystine 22 ± 3
L-H om ocysteate 21 ± 3
L-H om ocysteine
su lp h in a te
33 ± 2
S-Carboxym ethyl-L-
cysteine
36 ± 0.3
S-Carboxyethyl-L-
cysteine
55 ± 3
NH.
L -C ystath ion ine 62 ± 2
C O ,H
C O ,H
D ,L -m eso-L an th ion ine 63 ± 2
NH.
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U ptake of 100|iM 
3H -L -glu tam ate 
(% of C ontrol)
C o m p o u n d S tru c tu re
HN
L -Q uisquaiate 1 ± 0.4
.......NH
.OH
NH.
(RS)-4-Brom o-
h o m o lb o te n a te
7 ± 1
OH
Ibotenate 20 ±  1
c o 2h
37 ± 2L -a-A m inoad ipate
HgN
NH.lS ,3S-l,3-H om oA C PD 45 ± 1
L -Serine-O -sulphate 12 ±  1
NH.
D -Serine-O -sulphate 66 ± 2
C O ,H
S-Sulpho-L-cysteine 44 ± 3
S O ,H
34 ± 5
(3-L-ODAP
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U ptake of 100|iM 
3H -L -g lu tam ate  
(% of Control)
C o m p o u n d S tru c tu re
NH
(RS)-5-Bromo-
vvillardiine
64 ± 1
NH.
■ C = | NCSSON
DIDS 12 ±  1
H,C
SITS 36 ± 1
OH
G allion 15 ± 3
0,N
LRM55 gliom a cell uptake of [3H]-L-glutam ate is reported  as m ean % of 
control ± S.E.M. The data for each com pound w as based on at least th ree  
duplicate  determ inations from  separate  experim ents. A verage control up take  
of [3H]-L-glutam ate in the cells w as 119 p m o l/m in /m g  protein . The assays 
were perform ed as described in M ethods and M aterials and have been 
corrected for non-specific uptake and  leakage.
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Figure 3.5 Competitive inhibition of high-affinity, chloride-dependent,
[3H ]-L -g lu tam a te  u p ta k e  in to  LRM 55 g lio m a  ce lls  b y  L -cystine .
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R epresentative L inew eaver-B urk  plot d em o n stra tin g  the com petitive  
inhib ition  of [3H l-L -glutam ate up take into LRM55 gliom a cells by L-cystine. 
The inset show s a rep lo t of K^pp vs [L-cystine]. The plots show n w ere 
generated using  the k-cat kinetic program  (BioM etallics Inc, Princeton NJ) 
w ith  w eighting  based on  constan t relative error, and  yielded values of: Km = 
48 ± 9 uM, Vmax = 323 ± 21 p m o l/m in /m g  pro tein  an d  = 48 ± 7 pM.
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Figure 3.6 Competitive inhibition of high-affinity, chloride-dependent,
[3H ]-L -g lu ta m a te  u p ta k e  in to  LRM 55 g lio m a  ce lls  b y  L -q u isq u a la te .
c 0.10
600
E 0.08 
a
S 0.06
400
200
0.04
a  0.02
0.00
0.00 0.05 0.10
1/ S (|iM L-glutam ate)
R epresentative L inew eaver-B urk  p lo t d e m o n s tra tin g  the com petitive  
inhibition of [3H ]-L-glutam ate uptake into LRM55 gliom a cells by L- 
quisqualate. The inset show s a replot of Kmiapp vs  [L-quisqualate]. The p lo ts 
show n w ere generated  using  the k-cat k inetic p ro g ram  (BioMetallics Inc, 
Princeton NJ) w ith  w eigh ting  based on  constan t re la tive  error, and yielded 
values of: Km = 61 ± 8  (xM, Vmax = 70 ± 5 p m o l/m in /m g  protein  and K, = 2 ± 
0.35 jiM.
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F igu re  3.7 C o m p etitiv e  in h ib itio n  of h ig h -a ffin ity , c h lo r id e -d e p e n d e n t, 
[3H ]-L -g lu ta m a te  u p tak e  in to  LRM 55 g lio m a cells by  (RS)-4- 
b ro m o h o m o ib o ten a te .
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R epresen tative  L inew eaver-B urk p lo t dem onstra ting  the com petitive  
inh ib ition  of [3H]-L-glutamate uptake into LRM55 gliom a cells by (RS)-4- 
b rom ohom oibotenate . The inset show s a rep lo t of Km.app vs  [(RS)-4-BrHI]. 
The plots show n w ere generated using  the k-cat kinetic p rogram  (BioMetallics 
Inc, P rinceton  NJ) w ith w eighting based on  constant relative error, and  
yielded values of: Km = 44 ± 2 jiM, Vmax = 58 ± 1 p m o l/m in /m g  pro tein  and K, 
= 18 ± 4 fiM.
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Table 3.4 K, values for inhibitors of high-affinity, chloride-dependent [3H]-
L-glutamate uptake in LRM55 glioma cells.
C o m p o u n d K, (pM)
L -G lutam ate 35 ± 0.4
(RS)-4-BrHI 18 ± 4
L-Cystine 49 ± 7
L-H om ocysteate 35 ± 2
Ibotenate 31 ± 3
L-Q uisqualate 5 ± 3
L -Serine-O -sulphate 26 ± 5
The values reported  in this table represent the average Kt values ± S.E.M. as 
de te rm ined  in at least 3 separate L inew eaver-B urk  analyses (see 
represen tative  plots, Figures 3.5 - 3.7) of the inh ib ition  of ch lo ride-dependen t 
up take  of [3H]-L-glutam ate in LRM55 gliom a cells. The p lots w ere prepared 
using  the k-cat kinetic p rogram  (BioM etallics Inc., P rinceton, NJ) w ith  
w eighting  based on  constant relative error. Kj values w ere estim ated on the  
basis of a rep lo t of Kmapp values.
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Chapter 4: Pharm acology of High-Affinity, C hloride-D ependent L-Glutamate 
Transport in G lial Tum our Cell Lines.
Introduction
T um ours of glial o rig in  (e.g., g liob lastom as, astrocytom as and  
o ligodendrom as) are  am ong  the m ost com m on , m ost lethal and  least 
treatable of the p rim a ry  tu m o u rs  occurring in the  C N S (for review  see: Giles 
and G onzales, 1995). D espite the trea tm en t o f these tum ours  w ith  
m ultim odal th e rap ies  includ ing  surgery, rad io th e ra p y  and  chem otherapy , 
m ean su rv iv a l in pa tien ts  diagnosed w ith  a m a lig n a n t glioblastom a is one  
year past trea tm en t, w ith  only 5% of all treated  p a tie n ts  su rv iv in g  five-years. 
C urrent in te rv e n tio n s  in  the treatm ent of these tu m o u rs  are ham pered  in  
several ways. Surgical rem oval is rarely co m p le te  d ue  to lack of d istinct 
boundaries be tw een  these tu m o u rs and the su r ro u n d in g  parenchym a. M ost 
recurrences of these  tum ours after surgery are a t th e  p rim ary  site. The use of 
radiotherapy an d  chem otherapy  is usually lim ited  d u e  to its lack of specificity 
and the cytotoxic effects on  norm al cells. G iven  these inadequacies, new  
therapies for g lial tu m o u rs  are very m uch  n eed ed . The developm en t of 
novel therapeu tic  stra teg ies for gliomas often res ts  w ith  the identification and  
exploitation of a b iochem ical process that d iffe ren tia tes neoplastic cells from  
norm al cells. Several lines of evidence indicate th a t the  increased expression 
of high-affinity, ch lo rid e-d ep en d en t L -glutam ate tran sp o rt m ay be one such
51
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! difference. The localisation of this tran sp o rt m echan ism  appears to be o n
glial cells. It has been dem onstrated  tha t a L -quisqualate-sensitive, ch lo ride- 
dependen t L -glu tam ate binding site is p resen t on  m em branes p repared  from  
purified  cu ltu res of p rim ary  astrocytes (Bridges et al., 1987b). Further, s tud ies 
using  im plan ta tion  of prim ary  cultures of astrocytes into the CNS produced  a 
sm all astrocyte-enriched area th a t could be v isualised  bo th  
im m unocytochem ically  (GFAP) and au torad iograph ica lly . H ere again, it was 
possible to dem onstra te  the presence of a glial, L -quisqualate-sensitive, 
ch lo ride-dependen t L-glutam ate b ind ing  site (1987a). In ano ther study, 
lesions to the den tate  gyrus m olecu lar layer of rats resu lted  in an  
up regu la tion  of ch lo ride-dependent L -glu tam ate b ind ing  w hich  coincided 
w ith  areas of increased gliosis and  GFAP expression  (A nderson et al., 1991). 
Of particu lar relevance are several stud ies th a t repo rt ch lo ride-dependen t L- 
g lu tam ate tran sp o rt is enriched on glial tu m o u r cells. In C6  ra t gliom a cells 
approxim ately  55% of L-glutam ate up take  m easu red  is m ediated  th ro u g h  
system  xc' (Cho and  Bannai, 1990). As deta iled  in the  prev ious chapter, w e 
have also dem onstra ted  that 32% of L -glu tam ate up take  in LRM55 rat g liom a 
cells is a ttribu tab le  to ch lo ride-dependen t system s w ith pharm acology 
consistent w ith  th a t of system xc (i.e., L -quisqualate, L-hom ocysteate and  L-a- 
am inoad ipate  are po ten t inhibitors). C onsiderably  fewer studies have been 
carried ou t in h u m a n  cell lines, a lthough  a report u tilising h um an  U C ll 
astrocytom a ceils has dem onstra ted  that ch lo ride-dependen t up take accounts 
for as m uch as 80% of total L-glutam ate tran sp o rt in these cells (Johnson and
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Johnson, 1993). Based on  these observations it appears logical to establish 
w hether ch lo ride-dependen t L-glutam ate transport is over expressed in  
hum an  gliom a cell lines. In this chapter, a survey of h igh-affin ity , chloride- 
dependen t L-glutam ate tran spo rte r activity in a varie ty  of h u m an  glial 
tum our cell lines is characterised. A library of co m pounds that defines the  
pharm acological profile of this transport system is u tilised  to  determ ine  the  
identity  of these sites.
Results an d  D iscussion
Ionic dependence of  L-glutamate transport in human glial tumour cell lines.
The hum an  glial tu m o u r cell lines listed in Table 4.1 w ere assayed to 
establish the natu re  of the  high-affinity L-glutam ate tran sp o rt system s 
present. The am oun t of up take  attributable to e ither so d iu m -d ep en d en t o r 
ch lo ride-dependent tran sp o rte r activities was evaluated  by follow ing the 
uptake of [3H]-L-glutam ate (100 fiM) in buffer in w hich ch lo ride  and  so d iu m  
were selectively replaced w ith  gluconate and choline, respectively. T he 
hum an  glial tum our cell lines em ployed for these stud ies included: U-373 
MG (glioblastom a-astrocytom a), U-87 MG (glioblastom a-astrocytom a), SNB-19 
(m alignant g lioblastom a-m ultifo rm e), CCF-STTG1 (astrocytom a grade IV) 
and SW-1088 (astrocytom a).
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Sodium-dependent  uptake in human glial tum our  cell lines.
The u p tak e  of L -glu tam ate  into the various glial tu m o u r cell lines was 
m ed iated  by bo th  so d iu m -d ep en d en t and  ch lo rid e -d ep en d en t tran sp o rt 
m echanism s (Table 4.1). The sod ium -dependen t L -g lu tam ate  uptake rate was 
found to be sim ilar in  all the  cell lines (i.e., U-373 M G, 199 ± 14; U-87 MG, 103± 
13; CCF-STTG1, 113 ± 7; SW-1088, 144 ± 7 p m o l/m in /m g  protein), w ith  th e  
notable exception  of the SNB-19 cell line (577 ± 82 p m o l/m in /m g  protein). 
These data  show  that the up take  of L-glutam ate is com parab le  to the so d iu m - 
d ep en d en t u p tak e  rate p rev iously  dem onstra ted  in  the LRM55 gliom a cells 
(239 ± 11 p m o l/m in /m g  protein). In contrast, the  so d iu m -d ep en d en t up take  
of L -glu tam ate appears to be greatly reduced in  the  gliom a cells w h e n  
com pared  to the  up take  of [3H]-L-glutam ate (100 p.M) in norm al p rim ary  
astrocytes (both rat and  h u m an ), approxim ately  6 -2 0  n m o l/m in /m g  p ro te in  
(Cho and  B annai, 1990; Flott an d  Siefert, 1991; W h ittem o re  et al., 1994). A 
sim ilar decrease in  so d iu m -d ep en d en t tran spo rt activ ity  was also reported in  
several o th er h u m a n  glial tu m o u r cell lines, includ ing : D-54 MG, D-65 MG, 
U-138 MG, U-251 MG and  U-235 MG (Ye and  Sontheim er, 1999).
Chloride-dependent uptake in human glial tumour cell lines.
The ra te  o f ch lo ride-dependen t L -glutam ate u p tak e  in  the hum an  glial 
tu m o u r cell lines w as found  to vary depend ing  on  the  line tested (Table 4.1).
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The m ost p ro n o u n ced  uptake was found in the  SNB-19 cell line (824 ± 75 
p m o l/m in /m g  protein), w hich is derived  from  a m alignan t g lioblastom a. 
U ptake in U-87 MG, CFF-STTG1 and U-373 M G, all h igh  grade astrocy tom a 
derived  cell lines, w as found to be 649 ± 79, 484 ± 19 and  161 ± 10 
p m o l/m in /m g  p ro tein , respectively. The SW-1088 cell line, w hich  was 
established  from  an  astrocytom a, p roduced  an  up take  rate of 165 ± 10 
p m o l/m in /m g  p ro tein . Interestingly the c o n trib u tio n  of ch lo rid e-d ep en d en t 
up take  w as found  to account for approx im ately  45 % or m ore of the total L- 
g lu tam ate  tran sp o rt (sod ium -dependen t an d  ch lo ride-dependen t uptake) in  
each of the cell lines. Proportionately, the U-87 MG cell line derived  from  a 
g lioblastom a-astrocytom a displayed the h ighest relative level of ch lo ride- 
dep en d en t tran sp o rt (86  % of total [3H ]-L-glutam ate transport). C hlo ride- 
d ep en d en t L -glu tam ate uptake also accounted  for the m ajority of total L- 
g lu tam ate  tran sp o rt in  the CCF-STTG1 ceils (81 % of total [3H ]-L-glutam ate 
transport). In the SNB-19 cell line, w hich  p roduced  the h ighest rate of 
ch lo ride-dependen t transport, relative up take  w as only 59 % of total. The U- 
373 MG an d  SW-1088 cells expressed a lm ost equal activities of so d iu m - 
dep en d en t and  ch lo ride-dependent tran spo rt, w ith  ch lo rid e-d ep en d en t 
up take responsib le  for 45 % and 53 % of total tran spo rt, respectively. In bo th  
instances, the rate of uptake and % of total up take  for ch lo ride-dependen t 
transport w ere found  to be higher in all of the  h u m an  cell lines than  in the  
LRM55 gliom a cell line (see C hapter 3).
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Pharmacology of  chloride-dependent uptake in human glial tumour cell 
lines.
The pharm acological characterisation  of the h igh-affin ity , ch loride- 
dependen t L -glutam ate tran spo rt site in the LRM55 gliom a cells provided a 
tool and a strategy' by w hich to com pare and determ ine  the activity of these 
transporters in o ther cell lines. As reported  in the p rev io u s  chapter, the  
uptake of [3H ]-L-glutam ate in the presence of ch loride an d  the  absence of 
sodium  w as no t inhibited  by w ell know n blockers of the so d iu m -d ep en d en t 
system  (e.g., D -aspartate or L-tnms-2,4-PDC). In contrast, the up take  of [3H]-L- 
glutam ate quan tified  u n d er these ionic conditions w as effectively a ttenuated  
by a n u m b er of EAA analogues (e.g., L-cystine, L -quisqualate and (RS)-4- 
brom ohom oibo tenate). The pharm acological profile ob tained  from  these 
studies po in ts  to the existence of a un ique pharm acopho re  for a chloride- 
dependent tran sp o rt site. The pharm acological profile of this site was also 
sim ilar w ith  the profile of the p rev iously  characterised cystine /g lu tam ate  
exchanger, system  xc\  U sing such a select series of com pounds, we assayed 
ch lo ride-dependen t [3H ]-L-glutam ate transport in the h u m an  tum our cell 
lines.
The library of com pounds u tilised  to investigate  the  chloride- 
dependen t up take  in h u m an  tu m o u r cell lines is sum m arised  in Table 4.2. 
The com m only  used so d iu m -d ep en d en t transporter substra te, D-aspartate 
(500 nM), exhib ited  a vary ing  p a tte rn  of inhibition of w ith  respect to chloride-
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dependent up take (100 |iM  [3H]-L-glutamate). For exam ple, SNB-19, U-373 MG 
and SW-1088 cells show ed  little sensitivity to D -aspartate (96 ± 3, 94 ± 2 and  83 
± 6 % of Control, respectively), w hilst a m arginally g reater effect was observed 
in the CCF-STTG1 (63 ± 2 % of Control) and  U-87 MG (45 ± 3 %  of Control) cell 
lines. The differential effects of D -aspartate in the h u m a n  tu m o u r  cell lines 
m ay indicate the presence of subtypes of ch lo ride-dependen t transporters. L- 
trans-2,4-PDC, ano ther p o ten t inhibitor of so d iu m -d ep e n d en t L -glutam ate 
transport d id  not significantly  decrease ch lo ride-dependen t u p tak e  of [3H]-L- 
glutam ate (100 (iM) in the  h u m an  tum our cell lines w h en  in c lu d ed  in assays 
at 500 nM. The lack of activ ity  of these com pounds m irro rs  the o bserva tion  
m ade in the LRM55 gliom a cells (see C hapter 3). In con trast, th e  inclusion  of 
500 (iM L-cystine p roduced  a po ten t inhib ition  of [3H ]-L -glutam ate uptake in  
each of the h um an  tu m o u r cell lines. The extent of in h ib itio n  w as greater 
than the inh ib ition  p ro d u ced  by 500 p.M L-glutam ate, w ith  th e  exception of 
the U-87 MG cells, w here  up take  was com pletely inhib ited  (i.e., rate of up take  
is ind istinguishable for background) by both L-cystine a n d  L-glutam ate. 
L-Cystine (100 ^iM) also p roduced  a po ten t inhib ition  of ch lo rid e -d ep en d en t 
transport, indicating a h igh  affinity for L-cystine and  a p o in tin g  to the identity  
of this uptake w ith  system  xc'. Again a sim ilar p a tte rn  of inh ib ition  was 
dem onstrated in the LRM55 gliom a cells. Several key EAA analogues h av e  
been identified as being  usefu l in defining the pharm acological profile of the  
ch loride-dependent tran sp o rt process. Of these co m p o u n d s , a n u m b e r 
isoxazole derivatives (e.g., L-quisqualate, (R S)-4-brom ohom oibotenate and
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ibotenate) have been  iden tified  as being am ongst the m ost p o ten t in h ib ito rs  
(Table 4.2). W hen in c lu d ed  in assays at 500 pM, L -quisqualate  produced  a 
m arked  reduction  in the  up take  of [3H ]-L-glutam ate. Decreasing th e  
concentra tion  of inh ib ito r to 100 pM resulted in a d im in ish ed , yet still p o ten t 
in h ib itio n  of up take  in  the  h u m an  tum our cell lines. Inclusion  of 500 pM 
(R S)-4-brom ohom oibotenate into the assays also resu lted  in the a lm o st 
com plete  inhib ition  of L -glutam ate uptake into each of the tu m o u r cell lines.
These find ing  lead to several in teresting  conclusions regard ing  the  
h igh  affinity, ch lo rid e-d ep en d en t L-glutam ate u p tak e  system . Firstly, it 
appears likely tha t the localisation of this site is on  glial cells, as p rev iously  
suggested by a n u m b er of reports (A nderson et al., 1991; Bridges et al., 1987a; 
Bridges et al., 1987b). As dem onstrated  by the cu rren t findings, the activity of 
the ch lo rid e-d ep en d en t system  is present on a range of cell lines o rig ina ting  
from  glial cell tum ours. The activity can be read ily  iso lated  and  stud ied  by the 
rem oval and  su b s titu tio n  of sod ium  w ith  choline. Interestingly , these  
findings also show  tha t ch lo ride-dependen t L -g lu tam ate  transport is 
m arked ly  increased in the glial tum our cell lines rela tive  to n o rm a l 
astrocytes, w here ch lo ride-dependen t system s only  con tribu te  to about 10 % of 
the total L -glutam ate tran sp o rt activity (Cho and B annai, 1990). This was 
consisten tly  observed  in  all of the cell lines, w h ere  ch lo rid e-d ep en d en t 
tran sp o rt accounted for no less th an  45 % of the to tal L -glutam ate tran sp o rt 
capacity. Taken w ith  the earlier reports dem onstra ting  the  increased levels of
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ch lo rid e-d ep en d en t tran sp o rt on  N 18-R E -neuroblastom a cells (M urphy  et al., 
1989), C 6  g liom a cells (Cho and  Bannai, 1990) and UC-11 h u m a n  astrocytom a 
cells (Johnson and  Johnson, 1993), it appears that enhanced  expression  of th is 
system  m ay be a ha llm ark  of glial tum ours. C lues to the iden tity  of th is 
tran spo rte r are  borne ou t th ro u g h  it's  pharm acological profile. T hus, up take  
of [3H ]-L-glutam ate u n d e r so d iu m -in d ep en d en t, c h lo rid e -d ep en d en t 
conditions w as poten tly  inh ib ited  by L-cystine, L -quisqualate and  (RS)-4- 
b rom ohom oibotenate , bu t w as unaffected by D -aspartate and  L-frans-2,4-PDC.
Significantly, this pharm acolog ical profile is once again  suggestive of 
the c y s tin e /g lu tam a te  exchanger, system  xc\  This system  has been  ex tensively  
characterised  in a variety  of cell types (see C hap ter 3). The cloning  of this 
transporter has revealed that it is com prised  of tw o distinct pro teins, xCT and 
4F2hc (Sato e t al., 1999). The xCT su b u n it is a ttribu ted  w ith  the tran sp o rte r 
activity, w h ils t 4F2hc has been  postu la ted  to play a role as a m o d u la to ry  
subunit. 4F2hc (also know n as CD98) has been associated w ith  a num ber of 
transport system s, including: LAT1 and  related p ro te ins E16 (hum an), TA1 
(rat) and  ASUR4b (Xenopus ), w h ich  m ediate  the  up take  of large n e u tra l 
am ino acids.
In terestingly , several stud ies h ave  dem onstra ted  an  up -regu la tion  of 
these system s in  a variety  of neoplasm s, includ ing  colon cancer and 
hepatocarcinom as (Sang et al., 1995; W olf et al., 1996; K anai et al., 1998; 
T orrents e t al., 1998; Pfeiffer e t al., 1999). It w as suggested that increased 
expression o f these transporters, w hich  now  appear to also include system  xc',
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m ay be necessary to m eet the increased need  for protein  synthesis in th e  
rapid ly  grow ing tu m o u r cells. In add ition  to this role, system  xc' is also 
th o u g h t to be critical in supp ly ing  L-cystine for g lu thath ione b iosyn thesis 
(Bannai and  K itam ura, 1980; Bannai and  K itam ura, 1981; Bannai and  Ishii, 
1982; Bannai and  K itam ura, 1982). Thus, studies have d em o n s tra ted  
in h ib itio n  of this site can decrease g lu ta th ione  levels and increase the  
vu lnerab ility  of certain  cells to oxidative dam age (M urphy et al., 1989). 
Related w ork  dem onstra ted  tha t dep le tion  of g lu thath ione  levels does n o t 
induce a cytotoxic response in norm al p rim ary  astrocytes, (Bridges et al., 1991). 
Taken together, it m ay be speculated  that the developm ent of n o v e l 
co m pounds that selectively a ttenua te  L-cystine transport m ight be ex trem ely  
beneficial in therapeutic  strategies based on  decreasing tu m o u r g lu ta th io n e  
levels for the pu rpose  of sensitising  the neoplastic  cells to either rad ia tion  o r 
cytotoxic treatm ents. W e are presen tly  p lann ing  on investigating  th is  
hypothesis by quantify ing  the expression  of the  ch loride-dependent g lu tam ate  
tran spo rte r (system  xc) in both  p rim ary  glial tum our biopsies and a n im a l 
tu m o u r m odels.
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Table 4.1 Ionic dependence of [3H]-L-glutamate uptake in human glial
tumour cell lines.
Cl' Free Na* Free
N a G luconate C holine Cl
p m o l/m in /m g  p ro te in
LRM55 239 ± 11 119 ± 7
U-373 199 ± 14 161 ± 10
U-87 103 ± 13 649 ± 79
SNB-19 577 ± 82 824 ± 75
CCF-STTG1 113 ± 7 484 ± 19
SW-1088 144 ± 7 165 ± 10
U ptake of [3H]-L-glutamate into h u m an  glial tu m o u r cell lines is reported as 
m ean p m o l/m in /m g  pro tein  ± S.E.M. The data for each ionic condition  was 
based on  at least duplicate  d e te rm in a tio n s each from  at least three separate  
experim ents. The assays w ere  perfo rm ed  as described in M ethods and  
M aterials and have been corrected for non-specific up take  and  leakage.
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Figure 4.2: Chloride-dependent uptake of [3H]-L-glutamate is reported as
m ean % of control ± S.E.M. The data  for each com pound was based on at least 
three dup licate  de te rm ina tions from  separate  experim ents. The assays w ere 
perform ed as described in M ethods and  M aterials and  have been corrected for 
non-specific u p tak e  and  leakage, n.d. denotes no t determ ined.
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Chapter 5: Cloning and Expression of the Cystine/Glutamate Exchange
Transporter, system  xc\
Introduction
T he tran spo rt of am ino acids across the plasm a m em brane of 
m am m alian  cells is m ediated by specific carrier system s w hich act on a 
discrete g roup  of substrate m olecules. The study of such transport system s is 
usually  d ep en d en t on the ability to isolate these m echanism s selectively and  
functionally  in o rder to characterise them . Some of the com m on obstacles 
encoun tered  du ring  such studies include low levels of expression of the  
p ro tein  of interest, the lack of specific substrates or inhibitors, the inability to 
discern the  presence of m ultip le  subtypes and the lack of in fo rm ation  on the  
m olecu lar s truc tu re  of the transporter. The study of ch lo ride-dependen t 
L -glutam ate transport in the m am m alian  CNS has, in m any respects, been 
ham pered  by  such difficulties.
A dvances in the understand ing  of this system has progressed w ith the 
u tilisa tion  of a num ber of tum our cell lines including, LRM55, C6  and  UC-11 
cells w h ich  exhibit increased levels of ch loride-dependent L-glutam ate 
uptake. These system s have allow ed specific substrates and  inhibitors to be 
identified  and  used  to m odel the pharm acological specificity of the respective 
sites. T he pharm acological profile characterised in the LRM55 gliom a cells 
suggests tha t the chloride-dependent L-glutam ate transport m echan ism
64
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presen t o n  these cells m ay be identical or closely related to the
cy s tin e /g lu tam a te  exchanger, system  xc\  The recent expression clon ing  of 
system  xc' from  activated m ouse pe rito n ea l m acrophages p rov ided  a n  
o p p o rtu n ity  to investigate this tran sp o rte r in isolation (Sato et al., 1999). It 
was fo u n d  th a t system  xc' was com prised  of tw o distinct proteins. The first 
p ro te in  w as revealed  to be identical to the  heavy  chain of the cell surface 
an tigen  4F2 (CD98 in m ouse). 4F2hc is an  integral m em brane p ro te in
classified as a type II m em brane N -g lycopro tein  and  hypothesised  to c o n ta in  
one to fo u r tran sm em b ran e-sp an n in g  dom ains. 4F2hc is u b iqu itously
d is tribu ted  in  all tissues and is believed to be invo lved  in num erous ce llu la r 
activities in  bo th  proliferating and  qu iescen t cells, including: cell a c tiv a tio n , 
cell g ro w th  an d  cell adhesion. E xpression of 4F2hc in Xenopus  oocytes 
induces the  transport of n eu tra l an d  basic am ino acids via  
tran sp o rte r/e x ch a n g e r activities sim ilar to the b°-'  and L system s (for rev iew  
see: Palacin  e t al., 1998). It is hypo thesised  th a t the surface expression and  
function  of these am ino acid tran sp o rte rs  requires the fo rm ation  of
d isu lp h id e -lin k ed  heterod im ers of 4F2hc w ith  a corresponding light ch a in  
possessing the  respective tran spo rte r activity. The second subun it in system  
xc‘ (term ed xCT) w as reported to be a novel p ro te in  w hich show ed sign ifican t 
hom ology w ith  a family of transporters th a t m ediate  cationic and zw itterion ic  
am ino acid tran sp o rt w hen co-expressed w ith  4F2hc (Sato et al., 1999). Co­
expression  o f 4F2hc and xCT in Xenopus  oocytes increased the uptake of bo th  
L-cystine a n d  L-glutam ate.
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In this chapter a clone of system  xc' from  m ouse brain is isolated a n d  
characterised  to establish the activ ity  and pharm acological profile of th e  
ch lo ride-dependen t, L-glutam ate u p tak e  m ediated  by this transporter.
Results and D iscussion
Functional expression of  LRM55 m R N A  in Xenopus oocytes a n d  
pharmacological characterisation of  chloride-dependent L-glutamate  
transport
The Xenopus  laevis oocyte expression  system  has been ex tensive ly  
u tilised  to s tudy  the in vitro  activ ities of tran spo rte r proteins. Poly(A)*- 
en riched  RNA (see Figure 5.1) w as isolated from  LRM55 gliom a cells an d  
injected into defolliculated stage IV-V Xenopus oocytes. The purified  LRM55 
m R N A  ap peared  to contain transcrip ts ranging  from  1.5 to 4 kilobases (kb) in  
size. The up take  of [3H ]-L-glutam ate (l|xM) w as quantified  in sodium -free frog 
R inger's so lu tion  w ith  choline rep lacing  sod ium . The injection of LRM55 
m R N A  induced  the expression of a ch lo ride-dependen t [3H ]-L-glutam ate 
tran sp o rt system  in the oocytes. The rate of [3H]-L-glutam ate up take w as 
quantified  a t 4 ± 1 fm o l/m in /o o c y te  at 3 days post injection, a level th a t 
increased to 107 ± 2 fm o l/m in /o o c y te  by 7 days post injection. This rate  of 
up take  w as 10-fold greater than  observed  in H 20-in jec ted  oocytes (Figure 5.2). 
An in itial kinetic study of this activ ity  y ielded Km and  Vmax values of 26 p.M
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and 480 fm o l/m in /o o cy te , respectively. The pharm acological profile of the 
ch loride-dependen t system  w as found to be consistent w ith  the specificity 
observed in the cu ltu red  LRM55 gliom a cells (Figure 5.3). Thus, [3H]-L- 
g lutam ate up take into the oocytes injected w ith  LRM55 m R N A  w as potently  
inhibited by L-cystine (100 M-M), w hilst little inh ib ition  w as p roduced  by the 
inclusion of 100 |iM  D -aspartate.
Molecular cloning of  system x c’ from murine brain cDNA libraries
M urine NIH-3T3 fibroblast and m urine  brain  cD N A  libraries were 
screened w ith  specific o ligonucleo tide  probes generated using  the published 
am ino acid sequences for the proteins w hich  com prise system  xc': xCT and 
4F2hc (Parm acek et al., 1989; Sato et al., 1999) accession no. AB022345 and 
X14309 in the GenBank database, respectively. In both  instances a single PCR 
p roduct w as detected for xCT and  4F2hc in each library w ith  approxim ate 
m olecular m asses of 1.5 - 1.6 kilobase pairs (kbp) (Figures 5.4 and  5.5). These 
fragm ent sizes correspond to the predicted num ber of nucleo tide  residues 
com prising the coding region sequences; 1.509 kbp for xCT and  1.581 kbp for 
4F2hc. The xCT and 4F2hc cDNA fragm ents from the m u rin e  brain library 
were, respectively, subcloned in to  the expression vectors pO G -l and  pBSKII(-) 
to yield the plasm ids pO G l-xCT and pBSK-4F2hc. The inco rpora tion  of the 
xCT and 4F2hc sequences w as confirm ed by  restriction enzym e m apping. The 
xCT coding cDNA sequence w as flanked by unique restriction sites for EcoR I
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and  Xba I a t the 5' and  3' ends, respectively. D ouble digestion of the pO G l-xC T 
p lasm id  w ith  EcoR I and  Xba I yielded tw o  fragm ents, 1.5 and  3.2 kbp in size 
(Figure 5.6). The sm aller fragm ent co rresponds to the xCT cDNA sequence, 
w hilst the larger represents the linearised p O G l plasm id. A sim ilar d igestion  
w as perform ed on the pBSK-4F2hc p la sm id  using  H ind  HI and Xba I. In th is 
case, initially  no fragm ent was p ro d u ced  from  the plasm id. F u rth e r  
investiga tion  suggested tha t the Xba I restric tion  site located 3' to the coding 
sequence w as defective. The use of ad jacen t restriction sites dow nstream  3' to 
the Xba I site, such as Sac II on the pBSKH(-) vector, resu lted  in the libera tion  
of an  approxim ately  1.5 kbp sized fragm en t co rresponding  to the 4F2hc 
sequence and a linearised 3.0 kbp pBSKII vector fragm ent (Figure 5.7).
xCT and 4F2hc sequence analysis
The p lasm id  pOGl-xCT contained  th e  cDNA sequence cloned from  a 
m urine  b ra in  cDNA library. Analysis of th e  nucleotide sequence predicted a 
p ro tein  of 502 am ino acids and a relative m o lecu lar m ass of a round  55.5 kDa 
(Figure 5.8). The a lignm ent of the xCT sequence from  m ouse brain w ith  the  
coding sequence of xCT in the m o u se  m acrophage highlighted som e 
differences in the nucleotide sequences, b u t  overall revealed a high degree of 
hom ology betw een the two clones (99 %). C om parison  of the xCT predicted 
pro tein  sequence w ith  the protein da tabases show ed significant hom ology (44- 
47 %) w ith  the recently identified hum an  a n d  rat clones of both the system  L-
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like an d  the h u m an  system  y'L-like tran sp o rte rs  (Kanai et al., 1998; 
M astroberard ino  et al., 1998; Torrents et al., 1998).
Sequence analysis of the cDNA insert for 4F2hc isolated from a m u r in e  
b rain  cD N A  library verified it's identity  w ith  the p rev iously  characterised 
m urine 4F2hc p ro te in  (Parm acek et al., 1989). Again, the degree of hom ology  
betw een  the tw o clones w as very h igh  (99 %), w ith  only  a sm all num ber of 
differences being  found in the aligned sequences (Figure 5.9).
Functional expression o f  xCT and 4F2hc in Xenopus oocytes
F unctional characterisation of the xCT and 4F2hc proteins was 
perfo rm ed  by expression  in Xenopus  oocytes. The coding  sequences of each 
cDNA insert in the p lasm ids (pOG l-xCT an d  pBSK-4F2hc) w ere transcribed in  
vitro  an d  yielded  the respective m R N A  transcrip ts  (Figure 5.10). Equal 
am oun ts of the xCT and  4F2hc m RNA, each of w hich w ere about 1.5 kb in  
size, w ere  injected into the oocytes. As sh o w n  in Figure 5.11, injection w ith  
xCT an d  4F2hc induced  chloride-dependent, [3H ]-L-glutam ate transport in th e  
oocytes. The rate of L-glutam ate (lpM ) u p tak e  in the oocytes was found to 
increase for several days after the in itial in jections (50 ng  total mRNA). T he  
up take of [3H ]-L-glutam ate became d istingu ishab le  from  background (i.e. 
up take in  H 20-in jec ted  oocytes) two days a fte r the in itial injection (185 ± 1 1  
fm ol/30  m in /o o cy te ) an d  continued to increase to the fifth  day post in jec tio n  
(1585 ± 780 fm ol/30  m in/oocyte). A sim ila r p a tte rn  of expression was
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observed  w h en  the a m o u n t of m RN A  injected w as reduced to 20 ng and 10 
ng  to tal m R N A , w ith  the rates of ch lo ride-dependent, [3H]-L-glutamate 
up take  m easu red  a t 1948 ± 172 and  1663 ± 230 fm ol/30  m in /oocy te , 
respectively, on  post in jection  day five. The injection of xCT m RNA (5, 10 
and  25 ng) alone, p roduced  no detectable increase in chloride-dependent, L- 
g lu tam ate  transport. In contrast, injection of sim ilar am oun ts of 4F2hc 
m R N A  induced  a sm all b u t insignificant increase in ch lo ride-dependen t 
tran sp o rt above background , 151 ± 49 fm ol/30 m in /o o cy te  w ith  25 ng total 
m RN A  at day  five.
Pharmacological characterisation of chloride-dependent uptake induced by 
xCT and 4F2hc in oocytes
The ch lo rid e-d ep en d en t activity induced by xCT and  4F2hc in oocytes 
was com pared  w ith  the  pharm acological profile obtained in the LRM55 cells 
in o rder to d e te rm in e  a possible correlation betw een the tw o systems. T he 
effect of a n u m b er of EAA analogues that define the ch lo ride-dependen t 
profile w as eva lua ted  (Figure 5.12). In all of the experim ents, the oocytes w ere 
injected w ith  50 ng  to tal m R N A  (xCT + 4F2hc) and  assayed a t five days post 
in jection in  the  absence of sod ium  (choline replacem ent). C onsistent w ith  
the activity  observed  in  the LRM55 cells, D -aspartate (10 pM) and  L-fnms-2,4- 
PDC (10 pM) d id  no t significantly  attenuate the ch lo ride-dependen t uptake of 
1 pM  L-glutam ate in to  the oocytes expressing system  xc' (90 ± 8  and  100 ± 10 %
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow ner. Further reproduction  prohibited w ithout p erm issio n .
71
of control). L-Cystine (10 p.M), w hich is a substrate for system  xc, as well as L- 
hom ocysteate (10 p.M) bo th  potently  inhibited the up take  of 1 p.M L-glutam ate. 
A series of isoxazole analogues, L-quisqualate, ibotenate and (RS)-4 - 
b rom ohom oibo tenate , w hich  have been p rev iously  identified as po ten t 
inhibitors of ch lo ride-dependen t system , m arkedly  reduced L-glutam ate 
accum ulation  into oocytes w hen  included at 10 pM. U ptake of L-glutam ate 
into the oocytes w as also d im in ished  by the presence of 10 pM L-serine-O- 
su lphate .
In sum m ary, tw o approaches w ere used to evaluate  the m olecular basis 
of the ch lo ride-dependen t g lu tam ate  transport activity. In the first, m R N A  
w as directly isolated from  the LRM55 cells and expressed in Xenopus  oocytes. 
In the second, the p ro te in  com ponents of system  xc‘, xCT and 4F2hc, were 
subcloned from  a m ouse cD N A  brain  library and  sim ilarly  expressed in the 
oocytes. In both  instances, the ionic dependence and  pharm acological 
specificity (e.g., sensitiv ity  to L-cystine, L-quisqualate, (RS)-4- 
brom ohom oibo tenate  and  ibotenate) were v irtually  identical, indicating that 
ch loride-dependent up take  of [3H]-L-glutam ate by the gliom a cells lines is 
very likely m ediated  by system  xc\  This conclusion is also supported by 
previous work in w hich a com parably  sized mRNA (1.5 to 4.0 kb) was isolated 
from  m ouse m acrophages and  sim ilarly  expressed in oocytes. Im portantly , 
the expressed tran spo rte r m ediated  the uptake of L-cystine in a m anner that
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w as sod ium -independen t and  com petitively inh ib ited  by L -glutam ate (Ishii et 
al., 1991).
W hile  fu tu re  studies will undoub ted ly  be focused on directly 
dem onstra ting  the presence of the system  xc' in tum ours, by  e ither W estern or 
N o rth e rn  analysis, the identity  of the ch lo rid e-d ep en d en t g lu tam ate  
transporte r w ith  system  xc" raise a num ber of in trig u in g  issues. In particular, 
au to rad iog raph ic  stud ies p reviously  dem onstra ted  tha t ch lo rid e-d ep en d en t 
g lu tam ate  b ind ing  sites exhibit a d istinct anatom ical d is trib u tio n  and can be 
d ifferentially  expressed follow ing CNS injury  (A nderson  et al., 1991). O ur 
p resen t findings suggest that these observations shou ld  now  be rein terp re ted  
to be rep resen ta tive  of system  xc\  W hether or no t such  in ju ry -induced  
changes in expression are related to the role of system  xc' in g lu ta th io n e  
synthesis and  oxidative protection are especially in te resting  and rem ain to be 
explored.
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Figure 5.1 Total RNA and poly (A)+-enriched mRNA isolated from
LRM55 gliom a cells.
1 2 3
Size-separation of RNA isolated from LRM55 glioma cells. Total RNA (100 
ng) (lane 1) and poly (A)+ enriched mRNA (5 ng) (lane 2) were separated 
through a 1% w /v  agarose gel and visualised with ethidium bromide. A 
molecular size marker, 1 kbp ladder, was run simultaneously (lane 3).
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Figure 5.2 Time-course for expression of chloride-dependent transport in
X e n o p u s  oocytes injected with LRM55 glioma cell mRNA.
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U ptake of [3Hj-L-glutam ate (10 p.M) in  Xenopus  oocytes w as quantified in the 
presence of chloride w ith  choline substitu ting  for sod ium  as described in  
M ethods and  Materials. U ptake is reported  as m ean ± S.E.M for at least 5 
separate  oocytes.
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Figure 5.3 Pharmacological comparison of chloride-dependent transport
in X en o p u s  oocytes expressing LRM55 glioma cell mRNA.
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U ptake of [3H]-L-glutamate (100 pM) in LRM55 glioma cells and (10 jiM) in  
Xenopus  oocytes was quantified in the presence of chloride w ith c h o lin e  
substitu ting  for sodium  as described in  M ethods and M aterials. A verage  
control up take  of [3H]-L-glutamate in  LRM55 glioma cells and X e n o p u s  
oocytes w as 168 ± 12 p m o l/m in /m g  pro tein  and 135 ± 7 fm o l/m in /o o c y te , 
respectively. U ptake is reported as m ean  % of Control ± S.E.M. for a t least 4 
separate experim ents conducted in duplicate  for LRM55 glioma cells and  at 
least 5 separate  oocytes.
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Figure 5.4 Isolation of xCT cDNA sequences from m ouse cDNA libraries.
1 2  3 4 5 6
Agarose gel (1% w /  v) electrophoresis o f xCT PCR products. Ladder is the 1 
kbp m arker (lane I). PCR reactions w ith  xCT oligonucleotide probes (0.2 nM) 
and ap p ro p ria te  cDNA tem plates (10 ng), C ontrol (HzO) (lane 2), NIH-3T3 dT 
(lane 4), NIH-3T3 Rand (lane 5) an d  total m ouse brain  (lane 6) w ere 
perform ed as described in M ethods an d  M aterials. 10 id of PCR reaction w as 
loaded in  each lane.
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Figure 5.5 Isolation of 4F2hc cD N A  sequences from m ouse cDNA
libraries.
1 2 3 4 5
Agarose gel (1% w /  v) electrophoresis of 4F2hc PCR products. Ladder is the 1 
kbp marker (lanes 1 and 5). PCR reactions with 4F2hc oligonucleotide probes 
(0.2 fiM) and appropriate cDNA templates (10 ng), NIH-3T3 dT (lane 2), total 
mouse brain (lane 3) and Control (HzO) (lane 4) were performed as described 
in Methods and Materials. 10 pi of PCR reaction was loaded in each lane.
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Figure 5.6 Restriction digest o f the pOGl-xCT plasmid.
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Agarose gel (1% w /v )  electrophoresis of pOGl-xCT restriction digest products. 
Restriction digestion's were performed as 20 |il reactions consisting of pO G l- 
xCT (2 ng) and enzymes (10 U) in appropriate buffer at 37 °C for 1 hour. 20 nl 
of digestion reaction was loaded in each lane. Ladder is the 1 kbp marker 
{lanes 1 and 5), Control (uncut plasmid) (lane 2), EcoR I + Xba I (lane 3) and 
EcoR I + Xho I (lane 4).
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Figure 5.7 Restriction digest o f the pBSK-4F2hc plasmid.
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Agarose gel (1% w / v )  electrophoresis of pBSK-4F2hc restriction digest 
products. Restriction digestions were performed as 20 jil reactions consisting 
of pBSK-4F2hc (1.5 ng) and enzym es (10 U) in appropriate buffer at 37 °C for 1 
hour. 20 nl o f digestion reaction was loaded in each lane. Ladder is the 1 kbp 
marker (lanes 1 and 7), Control (uncut plasmid) (lane 2), Kpn I + Sac II (lane 
3), Hind III + Xba I (lane 4), Hind III + Sac II (lane 5) and Xho I +- Xba I (lane 6).
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F ig u re  5.8 A lig n m e n t o f p re d ic te d  a m in o  ac id  se q u en c es  for xC T iso la ted
from m o u se m a c ro p h a g e s  a n d  b ra in .
m-xCT i MVRKPVVATISKGGYLQGNMSGRLPSMGDQEPPGQEKWLKKKITLLRGVSIIIGTV1GS 60
b-xCT i MVRKPVVATISKGGYLQGN MSGRLPSMGDQEPPGQEKWLKKK1TLLRG VSIIIGTVIGS 60
m-xCT 61 Gl FIS PKG1LQ NT GSVGMS LVF WSACGV LSLFG ALS YAE LGT SIKKSG GH YTYILE VFG P 120
b-xCT 61 GIF1SPKGILQNT GSVGMSLVFWSACGVLSLFGALSYAELGTSIKKSGGHYTYILEVFGP 120
m-xCT 121 LLAFVRVWVELLVIRPGATAVISLAFGRY1LEPFFIQCEI P ELA1KLVT A VGITVVMVLN 180
b-xCT 121 LLAFVRVWVELLVIRPGATAV1SLAFGRYILEPFFIQCENS ELAIKLVT P VGITVVMVLN 180
m-xCT 181 STSV SW SA R IQ IFLTFC K LT AILIIIVPGVIQL1KGQTHH FKD AFSGRDTSLM GLPLAFY 240
b-xCT 181 STSVSW SA R1QIFLTFCK LT AILII1VPGV1QL1KGQTHH FKD AFSGRDTSLM GLPLAFY 240
m-xCT 241 YGM YAYAGW FYLN FITEEVDN PEKTIPLAICISMAIITVGYVLTN VAYFTTISAEELLQS 300
b-xCT 241 YGM YAYAGWFYLNFITEEVDNPEKTIPLAIC ISMAIITVGYVLTN VAYFTTISAEELLQS 300
m-xCT 301 SAVAVTFSERLLGKFSLAVPIFVALSCFGSMNGGVFAVSRLFYVASREGHLPEILSMIHV 360
b-xCT 301 SAVAVTFSERLLGKFSLAVPIFVALSCFGSMNGGVFAVSRLFYVASREGHLPEILSM1H V 360
m-xCT 361 HKH TPLPA VIVLH PLTMVMLFSG DLYSLLNFLS FARWLFMGLA VAGU YLRYKRPDMH RP 420
b-xCT 361 HKHTPLPAV1VLH PLTMVMLFSGDLYSLLNFLSFARWLFMGLAVAGLIYLRYKRPDMHRP 420
m-xCT 421 FKVPLFIPALFS FTCLFMVVLSLYSD PFSTGVGFUTLT GVPAYYLFIVWDKKPKW FRR L 480
b-xCT 421 FKVPLFIPALFSFTCLFMVVLSLYSD PFSTGVGFUTLTGVPAYYLFIVWDKKPKW FRR L 480
m-xCT 481 SDRITRTLQIILEWPEDSKEL 502
b-xCT 481 SDRITRTLQIILEWPEDSKEL 502
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Amino acid sequence comparison of macrophage and brain xCT proteins in  
mouse and a hydropathy plot of m ouse brain xCT (Kyte-Doolittle hydropathy 
analysis using a w indow  of 17 amino acids). The abscissa indicates the amino  
acid number.
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Figure 5.9 A lign m en t of predicted am ino acid  sequ en ces for 4F2hc  
iso lated  from  m o u se  m acrophages and brain.
m-4F2hc i 
b-4F2hc I
MSQDTEVDMKDVELNELEPEKQPMNAADGAAAGEKN GLVK1KVAED ETEAGVKFTG LSKE 60 
MSQDTEVDMKDVELNELEPEKQPMNAADGAAAGEKN GLVKIKVAED ETEAGVKFTG LSKE 60
m-4F2hc 61 
b-4F2hc 61
ELUCVAGSPGW VRTRWALUXFWLGWLGMLAGAWIIVRAPRCRELPVQRW WHKGALYRI 120 
ELLKVAGSPGW VRTR W ALLLLFW LGW LGM LA GAW1IVR APRC R ELPVQR W W H KGALYRI 120
m-4F2hc 121 
b-4F2hc 121
GDLQAFVGRDAGGIAGLKSHLEYLSTLXVKGLVLGPIHKNOKDEINETDLKQINPTLGSQ 180 
GDLQAFVGPDAGGIAGLKNHLEYLSTLKVKGLVLGP1HKNQKDE1 NETDLKQINPTLGSQ ISO
m-4F2hc 181 
b-4F2hc 181
EDFKDU.QSAKKKSIH1ILDLTPNYQGQNAWFLPAQADIVATKMKEA1.SSWLQDGVDGFQ 240 
EDFKDLLQSAKKKSIHIILDLTPNYQGQNAWFLPAQADIVATKMKEALSSWLQ DGVDG FQ 240
m-4F2hc 241 
b-lF2hc 241
FR DVGKLMN APLYLAEW QNITKNLSED RLUAGTESS DLQOIVNILESTSDLLLTSSYLS 300 
FR DVGKLMN APLYLAEW QNITKNLSED RLUAGT ESS DLQQIVNI LEST SDLLLTSS YLS 300
m-4F2hc
b-4F2hc
301
301
NSTFTGERTESLVTRFLN ATGSQWCSWSVSQAGUADF1PDHLLRLYQLLLFTLPGTPVF 360 
NSTFTGERTESLVTRFLNATGSQWCSWSVSQAGLLADFIPDHLLRFYQLLLFTLPGTPVF 360
m-4F2hc
b-4F2hc
361
361
SYGDELGLQGALPGQPAKAPLMPWNESSIFHIPRPVSLNMTVKGQN EDPGSLLTQFRRLS 420 
SYGDELGLQGALPGQPAKAPFMPWNESSVFHIPRPVSLNMTVKGQNEDPGSLLTQFRRLS 420
m-»F2hc 421 
b-4F2hc 421
DLRGKERSLLHGDFHALSSSPOLFSYIRHWDQNERYLWLNFRDSGRSARLGASNLPAGI
DLRGKERSLLHGDFHALPSSPDLFSYIRHWDQNERYLWUNFRDSGRSARLGASNLPAGI
480
480
m-iF2hc 481 
b-3F2hc 481
SLPASAKLLLSTDSARQSREEDTSLKLENLSLNPYEGLLLQFPFVAZ
SLPASANLLLSTDSARQSREEGTSLKLENLSLNPYEGU.LQFPFVAZ
527
527
A m ino acid sequence com parison  of m acrophage and  b rain  4F2hc proteins i n 
m ouse .
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Figure 5.10 Isolation of xCT and 4F2hc mRNA transcribed in vitro from 
linearised plasmids, pOGl-xCT and pBSK-4F2hc.
1 2  3 4
Agarose gel (1% w /  v) electrophoresis of xCT and 4F2hc mRNA. xCT and 
4F2hc mRNA was synthesised in vitro as described by Kavanaugh et al., 
(1992). Ladder is the 1 kbp marker (lanes 1 and 4), 4F2hc mRNA (lane 2) and 
xCT mRNA {lane 3).
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow ner. Further reproduction  prohibited w ithout p erm issio n .
83
Figure 5.11 Time-course for the expression of chloride-dependent L-
glutamate uptake in Xenopus  oocytes injected with 4F2hc an d /or xCT
mRNA.
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Figure 5.11: Xenopus oocytes were injected w ith 10, 20 or 50 ng each of 4F2hc 
mRNA, xCT mRNA, or both. The uptake of 1 nM [3H]-L-glutamate was 
quantified in the presence of chloride with choline substituting for sodium  as 
described in M ethods and Material and has been corrected for non-specific 
uptake and leakage (i.e. uptake in H20  injected oocytes). Uptake is reported as 
mean ± S.E.M. for at least 5 separate oocytes.
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Figure 5.12 Pharmacological characterisation of chloride-dependent L-
glutamate uptake in X en opus  oocytes injected with 4F2hc and xCT mRNA.
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Figure 5.12: X enopus  oocytes w ere injected w ith  25 ng of both  4F2hc m R N A  
and  xCT m RNA. The uptake of 1 p.M [3H ]-L-glutam ate is repo rted  as m ean % 
of contro l ± S.E.M. The data for each co m p o u n d  w as based on  a t least th ree  
d e te rm in a tio n s. A verage contro l up take  of [3Hl-L-glutam ate in  the oocytes 
w as 3932 fm o l/3 0  m in /m g  protein . The assays w ere perform ed as described 
in M ethods and  M aterial and  have been corrected  for non-specific uptake and  
leakage (i.e. up take  in H zO  injected oocytes). Uptake is repo rted  as m ean ± 
S.E.M. % of C ontrol for at least 5 separate oocytes.
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Chapter 6: Summary and Conclusions
O ver the last three decades, there has been  a d ram atic  evo lu tion  in o u r  
know ledge and u n d e rs tan d in g  of the EAA n e u ro tra n sm itte r  system s in the 
m am m alian  cen tral nervous system . The m ajority of s tud ies focusing on the 
EAA transporters have concentrated on the pharm acolog ical and  m olecu lar 
characterisation  of the high-affinity, so d iu m -d ep en d en t system s (EAAT1-5). 
The w ork  p resen ted  in th is thesis characterised a m uch  less well understood  
g lu tam ate  transporter th a t is d istinguished by its dependence  on  chloride and  
independence on  sod ium . The first section of w ork  addressed the 
pharm acology and  kinetics of high-affinity g lu tam ate  tran sp o rt in a cell line  
(LRM55) that w as repo rted  to express both  the sod ium - and  chloride- 
dep en d en t system s (W aniew ski and  M artin, 1984). The results of these 
stud ies led to the follow ing conclusions:
• High-affinity uptake o f L-giutamate by LRM55 gliom a cells is comprised of 
two distinct system s that could be distinguished and selectively characterised 
by exploiting their ionic dependencies. U sing ionic substitu tions (e.g., 
gluconate for ch loride  and  choline for sodium ) it w as found  that the uptake 
of [3H ]-L-glutam ate into LRM55 gliom a cells could  be a ttribu ted  to a sod ium - 
d ependen t com ponent (65 %) and a ch lo ride-dependen t com ponent (35 %) of 
total transport. Kinetic analysis show ed bo th  sites had  a sim ilar kinetic 
constants for L -glutam ate uptake, Km and V max values of 58 ± 5 jiM and 365 ±
85
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16 p m o l/m in /m g  p ro tein  for sod ium -dependen t a n d  54 ± 3 pM and 169 ± 6 
p m o l/m in /m g  p ro te in  for ch loride-dependent system s.
• The pharmacological profile of chloride-dependent L-glutamate transport 
site in LRM55 gliom a cells is distinct from the sod ium -dependent sites but 
bears identity w ith the profile for the cystine/glutam ate exchanger, system xc\
Of the know n inhibitors of EAAT 1-5 that w ere ev a lu a ted  against the sodium - 
dependen t portion  of transport present in the LRM55 gliom a cells, L-trans-2,4- 
pyrro lid ine dicarboxylate was found to p o ten tly  inh ib it [3H]-L-glutamate 
influx th ro u g h  this site, w hilst d ihydrokainate  d id  not. This led to the  
conclusion tha t the sod ium -dependen t up take  in the  cells was m ediated by 
GLAST (EAAT1). C onsistent with this in te rp re ta tion , W estern analysis of the  
three tran spo rte r pro teins, GLAST, GLT-1 an d  E A A C l dem onstrated  sole 
expression of GLAST in LRM55 glioma cells.
D-A spartate, a substrate and a po ten t in h ib ito r  of the high-affinity, 
sod ium -dependen t L-glutam ate transporters w as inac tive  w ith  respect to the  
ch loride-dependent po rtion  of L-glutam ate u p tak e  in  the LRM55 glioma cells. 
A series of pyrro lid ine dicarboxylates, L-trans-2,4-pyrro lid ine  dicarboxylate (L- 
frans-2,4-PDC), L-frrms-2,3-pyrrolidine dicarboxylate (L-frans-2,3-PDC), 
d ihydrokainate  (DHK), L -anfz-endo-3,4-m ethanopyrrolidine dicarboxylate (L- 
anti-endo-3,4-MPDC) and  2 ,4-m ethanopyrro lid ine dicarboxylate (2,4-MPDC) 
were also ineffective as uptake blockers of th is system . In contrast, several 
analogues w ith in  a series of su lphur con ta in ing  am in o  acids e.g., L-cystine
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and  L-hom ocysteate, m arked ly  inh ib ited  ch lo ride-dependen t [3H ]-L -glutam ate 
up take  into the LRM55 gliom a cells. These d ianionic am ino acids acted w ith  
a sim ilar potency to that of L -glutam ate. O ther analogues w ith  m o d era te  
inh ib ito ry  activ ity  included L-hom ocysteine su lph inate  and S-carboxym ethyl- 
L-cysteine. L-Cysteine, form ed by  the  reduction of L-cystine, exh ib ited  little o r 
no effect. O f three isoxazole analogues evaluated  for the ab ility  to in h ib it 
h igh-affin ity , ch lo ride-dependen t transport, L -quisqualate p ro v ed  to be th e  
m ost potent. (R S)-4-brom ohom oibotenate possessed a greater activity  th a n  
ibotenate. A ll of these analogues, how ever, com petitively  in h ib ited  LRM55 
up take  w ith  K; values less than  th a t of L-glutam ate.
The resu lts of the stud ies w ith  the LRM55 cells, in com b ination  w ith  a 
n u m b er of lite ra tu re  reports, suggested that increased ch lo ride-dependen t L- 
g lu tam ate  tran spo rt activity  m ay  be a com m on characteristic of g lial tu m o u rs . 
In ligh t of this, the levels of ch lo ride-dependen t g lu tam ate  up take  w ere 
quantified  in  a series of h u m an  glial tu m o u r cell lines. The pharm aco log ica l 
profile ascertained in the LRM55 gliom a cells was also used to en su re  tha t the  
observed activities w ere m ed ia ted  by the sam e system . Several o f the m o re  
im portan t findings are sum m arised  below:
• The high-affinity, sod ium -dependent and chloride-dependent, L- 
glutamate transporters are differentially expressed in glial tum our cell lines.
It w as dem onstra ted  tha t the up tak e  of L-glutam ate via so d iu m -d e p e n d e n t
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processes is greatly reduced  in the glial tum our cell lines w h e n  com pared  to 
n o rm al astrocytes. This indicates a  reduced capacity of these cells to 
translocate extracellu lar L -glutam ate. In contrast, the glial tu m o u r  cell lines 
d isp layed  an increase in ch loride-dependen t L-glutam ate u p tak e  activity. T he  
con tribu tion  to the total activity of L-glutam ate was no t less th a n  50 % in each 
of the cell lines s tud ied . This is significantly higher than  m easu red  in norm al 
astrocytes, w here ch lo ride-dependen t transport m echanism s typically  account 
for less th an  10 % of total L -glutam ate transport. The levels of activity  
appeared  to correlate  w ith  the grade of the tum our, th u s  a m a lig n a n t 
glioblastom a p resen ted  w ith  the h ighest rate of uptake. A  g rea ter n u m ber of 
tum ours  at v a rious grades w ill need  to be assayed to p ro p erly  ev a lu a te  
w hether o r not such  a correlation  exists.
In each of the glial tu m o u r cell lines assayed, w ell k n o w n  so d iu m - 
d ep en d en t tran spo rt substrates (e.g., D-aspartate) and in h ib ito rs  (e.g., L-trans- 
2,4-PDC) had  little or no effect on  the chloride-dependent tran sp o rte r. On th e  
other h an d , com pounds identified as potent inhibitors of ch lo rid e -d e p en d e n t 
transport in the LRM55 gliom a cells each m arked reduced u p tak e  in  the o th e r  
glial tu m o u r cell lines. In particu lar, L-cystine, L -qu isqualate  and  (RS)-4- 
b rom ohom oibo tena te  p roved  to be am ong the most p o ten t blockers. Once 
again, the resu lting  pharm acological profile proved qu ite  s im ila r to that of 
the cy stin e /g lu tam a te  exchanger and  adds further stren g th  to the a rg u m e n t 
that the  tran sp o rt m echanism s are identical or very closely re la ted .
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A recent study  identified  the m olecular basis for system  x.' th ro u g h  
expression c lon ing  (Sato et al., 1999). It was d em o n stra ted  that system  xc is 
com prised of tw o d istinct proteins, xCT and  4F2hc, w hich form a 
heterodim er. In the final po rtion  of this study, a system  x.' clone w as isolated 
from a m u rin e  brain  cDNA library and expressed in X enopus  oocytes to 
com pare ch lo ride-dependen t g lu tam ate  uptake w ith  system  xc\  The m ost 
significant find ings of these experim ents are sum m arised  below:
• Chloride-dependent L-glutamate transport can be reproduced in an 
heterologous expression system . Pharm acological characterisation of 
ch lo ride-dependen t g lu tam ate  transport in X enopus  oocytes expressing total 
mRNA isolated from  LRM55 gliom a cells p rov ided  an  a lternative  approach 
to assess the  m olecu lar basis of this uptake system . C h lo ride-dependen t 
glutam ate tran sp o rt activity w as stably expressed over a period  of several days 
and was as observed  in  the cell line, inhibitable by  L-cystine, bu t unaffected by 
D-aspartate.
Screening of NIH-3T3 fibroblast and m urine brain  cDNA libraries w ith  
specific o ligonucleo tide probes for xCT and 4F2hc y ielded cDNAs sequences 
coding xCT and  4F2hc, the tw o proteins com prising  system  xc\  Sequence 
analysis confirm ed the xCT and  4F2hc clones from  the brain  library exhibited 
very h igh  levels of hom ology w ith  the original clones obtained from m ouse  
activated m acrophages (Sato e t al., 1999). These resu lts lead to the conclusion  
that system  xc' m ust be expressed in the NIF1-3T3 fibroblast cells and  to som e
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degree in the m ouse CNS. Injection of m R N A s for xCT and 4F2hc in to  
X enopus  oocytes resulted  in the expression  of ch lo ride-dependent L- 
g lu tam ate  tran spo rt activity. Im portantly , the  oocytes w ere devoid  of activity  
w hen  xCT w as expressed alone. Sim ilarly, w h en  4F2hc was expressed by 
itself, the oocytes expressed only very low levels of system  xc\  These findings 
p rov ide  evidence for the m odulatory  role of 4F2hc in the expression of xCT.
W hen pharm acologically  evaluated , ch lo ride-dependen t transport in  
the oocytes expressing xCT and 4F2hc p roved  to be alm ost identical w ith th a t 
observed in the various the glial tum our cell lines. Thus, D-aspartate or L- 
trans-2,4-PDC d id  no t inhibit system  xc‘, w h ile  L-cystine, L-quisqualate, (RS)-4- 
b rom ohom oibo tena te  and  L-hom ocysteate p roved  to be po ten t blockers. 
These findings su p p o rt the conclusion th a t ch lo ride-dependen t L-glutam ate 
up take in the gliom a cells is m ediated by the  cystine /g lu tam ate  exchanger, 
system  xc'.
O verall, the w ork  detailed in th is s tudy  contributes to a better 
u n d ers tan d in g  of high-affinity, ch lo ride-dependen t L-glutam ate transport in  
glial tum our cells. The identification of p o ten t inhibitors not only provides a 
library of blockers w ith  w hich investigate function , it also represents a n  
im p o rtan t starting  po in t in the d e lin ea tio n  of the substrate site 
p harm acophore  on  the transport protein. F u rthe r progress will be closely 
linked to the developm en t of add itional conform ationally  constra ined  
analogues.
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The e levation  of ch lo ride-dependen t tran sp o rte r ac tiv ity  in glial 
tu m o u r ceils suggests tha t the extent of L-cystine up take  a n d /o r  L -glutam ate 
efflux th rough  system  xc' m ay be im portan t in tu m o u r physio logy. A n  
increased req u irem en t for L-cystine m ay reflect an  increased  need for 
g lu ta th ione, as tu m o u r cells are typically d iv id ing  rap id ly  a n d  have  h ig h er 
m etabolic rates. W hile the significance of the h igh  levels of ch loride- 
dependen t tran sp o rt rem ain  to be explored, the possibility  th a t the  presence of 
the transporter m igh t be exploited  as a therapeutic  strategy sh o u ld  not be 
overlooked. T hus, presence of the ch lo rid e-d ep en d en t L -glutam ate 
transporter m ay serve as a d iagnostic m arker or as a selective p o in t of en try  
for im aging or toxic reagents. Furtherm ore , the in h ib itio n  th e  up take  of L- 
cystine th ro u g h  this system  m ay decrease g lu ta th ione  levels an d  render the  
tum our cells m ore  sensitive  to radio therapy and  ch em o th e rap y . T he 
pharm acological an d  kinetic studies presented in this thesis  p rovide a 
foundation from  w hich  to beg in  to explore these exciting possib ilities.
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